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1 INTRODUCTION 
Cells need to communicate with their environment, i.e. to receive signals from the 
surrounding environment and to respond to those signals appropriately as well as to 
send signals over shorter or longer distances. This intercellular communication will then 
determine whether a cell will proliferate, differentiate, or die, and whether it will adhere 
or migrate. Virtually all aspects of its behavior depend on the cells ability to accurately 
interpret signals. These extracellular stimuli are transmitted via their cell-surface 
receptors and ion channels. Cell surface receptors transduce a signal from a transmitter 
outside the cell across the plasma membrane to the appropriate targets within the cell. 
One large class of surface receptors are generally integral membrane proteins (or protein 
complexes) with transmitter binding sites located outside the cell, α-helical regions 
crossing the cell membrane and a cytoplasmic domain that generates a signal inside the 
cell upon transmitter binding (e.g. due to conformational change, dimerization). There 
are several major families of such receptors in the superfamily termed G protein-
coupled receptors (GPCRs). Nucleotide activated purinergic receptors (P2Y receptors) 
belong to the classical family 1 of GPCRs (Fig. 1.1), which undergo internalization and 
desensitization after activation by their agonists. According to the classification made 
by Bockaert and Pin (1999), GPCRs can be subdivided into 6 families (family 1-5, and 
cAMP receptor family) based on their respective ligands and binding sites. Once 
GPCRs are activated by their agonists, these receptors associate with and promote 
activation of heterotrimeric G proteins bound to the inside of the cell membrane. G 
proteins play important roles in determining the specificity and temporal characteristics 
of the cellular responses. The G proteins consist of three subunits, α, β, and γ. The α 
subunit binds GDP or GTP. The agonists activating family 1 GPCRs include peptide 
and non-peptide neurotransmitters, hormones, growth factors, odorant molecules and 
light. The interaction of the specific ligand with its GPCR – via activation of 
heterotrimeric guanine nucleotide binding proteins - initiates a signaling cascade 
leading to e.g. enhanced gene expression through activation of the mitogen-activated 
protein kinase (MAP kinase; MAPK) pathway, and thus regulate cell proliferation, 
differentiation, and motility. Abnormal signaling or prolonged activation of G-protein 
signaling pathways impairs normal functioning of various cells and tissues of our body. 
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Figure 1.1. Classification and diversity of GPCRs (Bockaert and Pin, 1999). (A) 
Three main families (1, 2 and 3) can be easily recognized when comparing their amino-
acid sequences. Receptors from different families share no sequence similarity, 
suggesting that GPCRs are a remarkable example of molecular convergence. Family 1 
contains most GPCRs including receptors for odorants. Group 1a contains GPCRs 
activated by small ligands and includes the rhodopsin and β-adrenergic receptors. The 
binding site is localized within the seven TMs. Group 1b contains receptors for peptides 
whose binding site includes the N-terminal, the extracellular loops and the superior 
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parts of TMs. Group 1c contains GPCRs for glycoprotein hormones. They are 
characterized by a large extracellular domain and a binding site which is mostly 
extracellular but at least with contact with extracellular loops e1 and e3. Family 2 
GPCRs have a similar morphology to group 1c GPCRs, but they do not share any 
sequence homology. Their ligands include high molecular weight hormones such as 
glucagon, secretin (Krasnoperov et al., 1997; Davletov et al., 1998). Family 3 contains 
mGluRs and the Ca2+ sensing receptors (Pin and Bockaert, 1995). However, GABA-B 
receptors (Kaupmann et al., 1997) and a group of putative pheromone receptors coupled 
to the G protein Go (termed VRs and Go-VN) became new members of this family 
(reviewed in Bargmann et al., 1997). (B) Family 4 comprises pheromone receptors 
(VNs) associated with Gi (Dulac and Axel, 1995). Family 5 includes the `frizzled' and 
the `smoothened' (Smo) receptors involved in embryonic development and in particular 
in cell polarity and segmentation. Finally, the cAMP receptors (cAR) have only been 
found in D.discoïdeum but its possible expression in vertebrate has not yet been 
reported. 
 
 
1.1 Purinergic receptors 
Purinergic receptors were first defined in 1976 and are now distinguished into 
two types of purinoceptors, named P1 and P2 for adenosine and ATP/ADP, respectively 
(Burnstock, 1978). All four subtypes of P1 receptors, namely A1, A2A, A2B and A3, 
are typical G protein-coupled (metabotropic) receptors and specific agonists and 
antagonists are available for each subtype (see Ralevic & Burnstock, 1998). The P2 
receptors, activated by extracellular nucleotides, are currently composed of the 
ionotropic P2X family and the metabotropic P2Y receptor family. The P2Y recceptor 
consists of 8 members which all have been cloned and functionally characterized 
(Abbracchio et al, 2003). with eight members The P2X receptors with seven subtypes 
including the P2X1, P2X2, P2X3, P2X4, P2X5, P2X6, and P2X7 have been identified as 
ligand-gated ion channels (Boeynaems et. al., 2005). The P2X receptors are involved in 
a wide variety of functions, like neurotransmission, vascular relaxation or constriction. 
 
 
1.1.1 The family of P2Y receptors 
The metabotropic P2Y receptors (P2Y1,2,4,6,11,12,13,14) are characterized by seven 
transmembrane spanning regions with a high level of sequence homology between some 
regions. The structural diversity of the intracellular loops and C-terminus among P2Y 
subtypes influences the degree of coupling with Gq/11, Gs and Gi proteins (Fig. 1.2). 
Each P2Y receptor binds to a single heterotrimeric G protein (typically Gq/11), 
although P2Y11 can couple to both Gq/11 and Gs, whereas P2Y12 couples to Gi. P2Y 
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receptors may form homo- and heteromultimeric assemblies under some conditions, and 
many cells express multiple P2Y receptor subtypes. P2Y receptors can be activated 
principally either by nucleotide diphosphates (P2Y1,6,12,13) or mainly by nucleotide 
triphosphates (P2Y2,4). Some P2Y receptors are activated by both purine and pyrimidine 
nucleotides (P2Y2,4,6) with the human P2Y4 and P2Y6 receptors are preferentially 
activated by the uracil-nucleotides UTP or UDP. Other P2Y receptors are activated by 
purine nucleotides alone (P2Y1,11,12,13). The P2Y2 receptor exhibits equal internal 
calcium increase in response to ATP or UTP (Abbracchio et al., 2003). Nucleotide 
activation of recombinant P2Y receptors either activates phospholipase C and release of 
intracellular calcium or affects adenylyl cyclase and thus alters cAMP levels. The 
recently discovered P2Y14 receptors does not show any preferential activation by purine 
or pyrimidine nucleotides, but is instead activated by UDP-glucose (Chambers et al., 
2000; Freeman et al., 2001). 
 
 
Figure 1.2: Two-dimensional structure of the human P2Y2receptor (Weisman et. 
al., 2005) Highlighted features include the consensus RGD integrin-binding domain, 
positively-charged amino acid residues involved in agonist binding , two consensus 
PXXP SH3-binding domains , and an incorporated hemagglutinin (HA) tag used for 
immunofluorescence and immunoprecipitation of various P2Y2 receptor constructs. The 
dotted line indicates the location of a truncation site for creation of a sequestration-
resistant P2Y2 receptor. 
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Site-directed mutagenesis of P2Y receptors, which has been carried out to probe for 
regions of agonist–receptor interactions, has suggested that four amino acid residues of 
the transmembrane (TM) regions TM6 and TM7 might be important for agonist potency 
and specificity (Barnard, E.A. and Simon, J. (2001), Erb et. al., 1995 and Jiang, et.al., 
1997). All cloned P2Y receptors share the TM6 H-X-X-R/K motif, which has been 
proposed to be crucial for agonist activity (Fig. 1.3). In P2Y1, P2Y2, P2Y4, P2Y6 and 
P2Y11 receptors, a Y-Q/K-X-X-R motif in TM7 has also been proposed to participate in 
ligand binding. In P2Y12 and P2Y13 receptors and in the UDP-glucose receptor (P2Y14 
receptor subtype), this motif is substituted with K-E-X-X-L. 
 
 
 
 
 
 
 
 
 
 
Fig. 1.3 Alignment of putative nucleotide binding motifs in human P2Y 
receptors. Binding motifs in transmembrane domain 6 (TM6) and TM7 of human (h) 
P2Y receptors are shown. Crucial amino acids for nucleotide binding are highlighted in 
red. Sequences were aligned using CLUSTALX. (From: Abbracchio et al., 2003)  
 
1.1.2 Expression and function of the P2Y2 receptor  
 The P2Y2 receptor is expressed in a wide variety of cells and tissues, including 
airway epithelial cells, fibroblasts, thymocytes, vascular smooth muscle cells, 
leucocytes and cardiomyocytes. In cells derived from the peripheral nervous system and 
the CNS, P2Y2 receptors have been identified in immortalized astrocytes, NG108-15 
neuroblastoma glioma hybrid cells, Schwann cells, dorsal horn and cortical astrocytes, 
astrocytoma cells, rat cortical neurons, and oligodendrocytes (Berti-Mattera et. al., 
1999, Gendron et. al., 2003, Ho et. al., 1995, Kirischuk et. al., 1995 and Weisman et. al., 
1999). In situ hybridization and reverse transcriptase–polymerase chain reaction (RT-
PCR) revealed that P2Y2 receptor messenger RNA (mRNA) was expressed at relatively 
low levels in normal rodent (i.e., rat, mouse, and gerbil) brain slices, but was most 
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abundant in the hippocampus and cerebellum. In the hippocampus, P2Y2 mRNA was 
highly expressed in the dentate gyrus and also detected in rat primary astrocytes, 
primary neurons, and microglial cells (Gendron et. al., 2003).  
The P2Y2 receptor subtype is distinguished in its ability to be upregulated under 
conditions of stress or injury in activated thymocytes, salivary gland epithelial cells, and 
models of vascular tissue injury (Koshiba et. al., 1997, Seye et. al., 2002 and Turner et. 
al., 1997). For example, P2Y2 receptor expression is dramatically increased in smooth 
muscle cells under conditions, which lead to intimal thickening which are correlated 
with the increased expression of osteopontin and the proliferation of smooth muscle 
cells (Seye et. al., 2002). Furthermore, P2Y2 receptor expression is upregulated by 
agents that mediate inflammation, including cytokines, interleukin (IL)-1β, interferon 
(IFN)-γ, and tumor necrosis factor (TNF)-α (Hou et. al., 1999 and Hou et. al., 2000 ). 
Consistent with a role for P2Y2 receptors in the proliferative phenotype, P2Y2 mRNA 
expression has been found to be downregulated during cell differentiation (Martin et. 
al., 1997). The P2Y2 receptor agonist UTP stimulates expression of mRNA of the 
cytokine transforming growth factor-β (TGF-β) in astrocytes (Gendron et. al., 2003). In 
urn, TGF-β regulates cell proliferation and differentiation that is dependent on 
activation of p38 and c-Jun NH2-terminal kinase (JNK) in cultured astrocytes (Gendron 
et. al., 2003).  
 
P2Y2 receptors mediate a wide variety of cellular responses of the extracellular 
nucleotides ATP and UTP. The physiological and/or pathological actions activated 
include such different cellular responses like pro-inflammatory responses, airway 
epithelial mucociliary clearance, regulation of cell proliferation or cell motility, and 
expression of cell adhesion molecules and cytokines (Lethem et. al., 1993, Miyagi et. 
al., 1996, Seye et. al., 2002, Muscella et. al., 2003 and Seye et. al., 2003). In several cell 
types, upregulation of P2Y2 receptors is associated with nucleotide-induced stimulation 
of PKC, cyclo-oxygenase, and MAPKs (Turner et. al., 1997, Turner et. al., 1998, 
Marrelli, et. al., 1999 and Kannan et. al., 2003). In primary murine astrocytes, P2Y2 
receptors mediate the activation of calcium-dependent and–independent PKCs and 
extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) to regulate the activity 
of cytosolic phospholipase A2 (cPLA2) (Xu et. al., 2002 and Gendron et. al., 2003), 
which hydrolyzes cell membrane phospholipids to produce arachidonic acid (AA) 
(Dennis, 1994), a precursor of pro-inflammatory chemokines, such as eicosanoids, 
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prostaglandins, and leukotrienes (Balsinde et. al., 2002). Prostaglandin E2 (PGE2) is a 
mediator of inflammation in the neuroendocrine and immune systems (Kopp et. al., 
2001, Vancheri et. al., 2004) and a potent vasodilator that acts with other chemokines to 
increase microvascular permeability in the peripheral nervous system (Karaki and 
Kuwahara, 2004, Ferreira et. al., 1997). Prostaglandins, including PGE2, have been 
shown to promote inflammatory responses associated with a number of diseases (Kopp 
2001 and Vancheri et. al., 2004). The ability of ATP and UTP to enhance cytokine-
induced inflammation strongly suggests that P2Y2 receptor modulate the actions of 
cytokines in neurodegenerative diseases. Furthermore, P2Y receptors mediated release 
of AA and activation of type 2 cyclooxygenase (COX-2) play a role in inflammation 
and reactive astrogliosis in neurodegenerative diseases (Brambilla et. al., 1999 and 
Brambilla and Burnstock 2000). 
The P2Y2 receptor does not only act as a single GPCR but has also been found 
to be functionally coupled with other P2 receptors. Together with the P2Y1 receptor the 
P2Y2 receptor activation caused arachidonic acid release from cultured astrocytes (Chen 
et. al., 1998) and also mediates neuroinflammatory responses in astrocytes and 
microglial cells together with coactivated P2X7 nucleotide receptors (Gendron et. al., 
2003).  
 
1.1.3 Functional coupling of the P2Y2 receptor to other receptors 
The P2Y2 receptor has been demonstrated to transactivate the epidermal growth 
factor receptor (EGFR) by interactions with its proline-rich consensus Src-homology-3 
(SH3)-binding domain, PXXP (P is proline and X is any amino acid) (Liu et. al., 2004). 
Immunofluorescence experiments showed that the SH3 binding domains in the P2Y2 
receptor facilitated its colocalization with the EGFR in response to P2Y2 activation by 
nucleotides. The proline-rich peptide sequences have been shown to play important 
roles in protein–protein interactions that occur in signal transduction pathways. For 
example, the SH3 domain in the β3 adrenergic receptor interacts directly with Src to 
activate ERK1/2 (Cao et. al., 2000). PXXP motifs in the β1 adrenergic and dopamine 
D4 receptor interact with endophilins, SH3 domain-containing proteins, to mediate 
receptor internalization and receptor coupling to G-proteins (Green and Liggett 1994, 
Tang et. al., 1999), adenylyl cyclase, and MAP kinase (Oldenhof et. al., 1998). 
Activation of GPCRs often causes the concomitant activation of growth factor 
receptors, although the mechanism controlling this transactivation is unclear (Luttrell et. 
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al., 1997, Andreev et. al., 2001). Previous studies have indicated that Src and Pyk2 are 
involved in the signaling pathway for growth factor receptor (GFR) transactivation by 
some GPCRs, including the P2Y2 receptor and protease activated receptor-1 (PAR1 
receptor) (Soltoff 1998 and Wang et.al., 2002), although researchers are divided in their 
opinion about the role of this pathway in the activation of downstream mitogenic 
signaling by GPCRs. For example, studies with EGFR/Src/Pyk2 dominant negative 
mutants or an EGFR kinase inhibitor demonstrated the importance of EGFR/Src/Pyk2 
in P2Y2–mediated MAPK activation in rat-1 fibroblasts and PC12 cells (Soltoff et. al, 
1998). In contrast, studies with embryonic fibroblasts derived from Src–/–, Pyk2–/–, or 
Src–/–Pyk2–/– mice suggested that Src/Pyk2 are essential for GPCR-mediated 
transactivation of the EGFR but are dispensable for GPCR-mediated MAPK activation 
(Andreev et. al., 2001). Two PXXP motifs were identified in the intracellular carboxy-
terminal tail of the human P2Y2 receptor that mediate GFR transactivation induced by 
ATP or UTP (Liu et. al., 2004). Although activation of the P2Y2 receptor mediates 
ERK1/2 phosphorylation, studies indicate that deletion of the SH3-binding motifs of the 
P2Y2 receptor did not suppress ERK1/2 activation (Liu et. al., 2004), most likely 
because of the ability of the P2Y2 receptor to also activate Src and ERK1/2 via P2Y2 
receptor-mediated transactivation of the integrin signaling pathway. 
Another binding motif contained in the P2Y2 receptor couples it to the 
thrombospondin receptor (CD47). The P2Y2 receptor contains the consensus integrin 
binding motif, Arg-Gly-Asp (RGD) in its first extracellular loop (as shown in Fig.1.4) 
(Erb et. al., 2001). The RGD motif functionally couples the P2Y2 receptor to αvβ3/β5 
integrins and it has been demonstrated that the P2Y2 receptor colocalized with αvβ3/β5 
integrins when the recombinant P2Y2 receptors was expressed in human 1321N1 
astrocytoma cells. These cells are devoid of endogenous G protein-coupled P2Y 
receptors. In addition, as revealed with a mutant P2Y2 receptor in which the RGD motif 
was replaced with Arg-Gly-Glu (RGE), the RGD motif does not only provide tight 
coupling to the integrins, but is also necessary to maintain the P2Y2 receptor in a high-
affinity ligand binding state, as the. EC50 for nucleotide-induced calcium mobilization 
was approximately 1000-fold greater for the RGE mutant (Erb et. al., 2001). 
Furthermore, the RGE-mutant P2Y2 receptor is not any longer sensitive to pertussis 
toxin-mediated uncoupling of the receptor from Go-protein, suggesting that association 
with αvβ3/β5 enabled access to the Go protein-coupled, integrin-associated 
thrombospondin receptor (CD47) and its signaling pathway. 
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The αvβ3/β5 integrins are widely expressed in cells of the cardiovascular system and 
play critical roles in angiogenesis and inflammatory responses, including cell 
proliferation, migration, adhesion, and infiltration (Zhang et. al., 2002; Hutchings et. al., 
2003, Li et. al., 2003 and Pidgeon et. al., 2003). Activation of P2Y2 receptors by UTP 
and ATP induces proliferation and/or migration of human epidermal keratinocytes, lung 
epithelial tumor cells, and smooth muscle cells (Wilden et. al.,1998, Schäfer et. al., 
2002 and Greig et. al.,2003). 
The different pathways found to be activated by the P2Y2 receptor are summarized in 
the schematic outline (Fig. 1.4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 Schematic outline of the signaling pathways mediated by the 
activated P2Y2 receptor. The activation of the P2Y2 receptor by ATP or UTP 
activates a number of pathways and also leads to transactivation of the growth factor 
receptor signaling pathways. (From: Weisman et al., 2005)  
 
1.1.4 Regulation of P2Y receptor-mediated signal transduction 
The mechanism of internalization and the intracellular trafficking of P2Y 
receptors has not been studied in detail. Internalization pathways have been reported for 
the β2-adrenergic receptor, including ligand-stimulated endocytosis (Claing et. al., 
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2002) and downregulation that is independent of endocytosis (Jockers et. al., 1999) 
Receptor endocytosis is a complex process that involves the recruitment of a number of 
proteins to the plasma membrane, such as arrestins, clathrin and AP2 (Claing et. al., 
2002), and translocation to the early endosomal compartment and lysosomes (McArdle 
et. al., 2002). This process is also known to be regulated by the cholesterol content and 
fluidity of the plasma membrane (Kwik et. al., 2003). Extraction of cholesterol from the 
plasma membrane with methyl-β-cyclodextrin (MβCD) has been reported to inhibit 
clathrin-mediated receptor endocytosis (Rodal et. al., 1999). Besides clathrin-mediated 
receptor endocytosis it can occur through caveolin-mediated pathways (McArdle et. al., 
2002). Receptor endocytosis from the plasma membrane and intracellular trafficking 
require massive rearrangement of the cytoskeleton mediated by cytoskeleton-associated 
proteins (Qualmann et. al., 2000). Agonist stimulation of P2Y receptors has been 
reported to result in the reorganization of the actin cytoskeleton in myocytes (Sauzeau 
et. al., 2000). However, a role for the actin cytoskeleton in P2Y receptor endocytosis 
was not clearly established. The targeting of the mannose-6-phosphate receptor from 
early endosomes to other compartments, such as late endosomes, lysosomes, or 
recycling endosomes is directed via the multivesicular body (Miwako et. al., 2001). An 
interesting regulatory step that could play a role in directing receptors from endosomes 
to lysosomes is the proteasome complex. Ubiquitin and the proteasomal pathway have 
been implicated in lysosomal targeting and degradation of the growth hormone receptor 
(Kerkhof et. al., 2001).  
The role of kinases has been postulated in the desensitization and resensitization 
of GPCR. In case of GPCRs the rate of internalization and reappearance is controlled by 
a number of factors, which include the association of the receptor with arrestin and the 
phosphorylation state of the receptor. It is know that in HEK 293 cells that express 
either the beta-2 adrnergic receptors or the vasopresin 2 receptor the rate of endocytosis 
of the receptor is different because of the differential association of the receptors which 
arrestin that cause the difference in the rate of trafficking though both of the receptors 
are phopshorylated before endocytosis (Oakley t. al., 1999). However it s know that for 
the delta opiod receptor there is a both a phosphorylation and phosphorylation-
independent internalization of the receptor that takes place. The phosphorylation of the 
receptor in this case is mediated via the GPCR coupled kinases (GRK) (Zhang et. al, 
2005). Stimulation of the P2Y2 receptor results in the rise of intracellular calcium and 
the production of DAG. These can in turn activate kinases like Ca2+/calmodulin-
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dependent protein kinase II (CamK-II) or protein kinase C (PKC) or 
Phosphatidylinositol 3-kinase (PI3K). In case of P2Y2 there are amino acid residues in 
the third intracellular loop and the C-terminal that are potential sited for 
phosphorylation by CaMK-II and PKCs (Garrad et. al., 1998). The family of CaMK-II 
consists of 4 different genes namely (α, β, γ, and δ) and there are to date 38 different 
isoforms of the CaMK-II (Tombes et. al., 2003). The CaMK-II is almost expressed in 
all tissue and plays a role in number of process like modulating the function of beta 
adrenergic receptor response (Zheng et. al., 2004) and also modulating the function of 
the SERCA pumps in the endoplasmic reticulum (Frank et. al., 2003). However the role 
of CaMK-II in modulating the trafficking of GPCRs and in endocytotis is yet to be 
clearly elucidated. CaMK-II is known to play a role in desensitization and endocytosis 
of the P2Y1 receptor (Tulapurkar et. al., 2006) and also for other GPCRs (Kawakami et. 
al., 2003). The role of CaMK-II and PKC in modulating the desensitization and 
internalization of metabotropic glutamate receptor-1a is well known too (Mundell et. 
al., 2004). Protein kinase C is an important family of kinases that has been widely 
investigated for its role in modulating different cellular processes. The PKC family 
consists of a total of 19 members that have been subdivided into families depending on 
their requirement for Ca2+, phosphatidylserine and diacylglycerol (DAG) for activation. 
The classical or conventional PKCs (α, βI, βII, γ) require all of the three mentioned 
factors for their activity, novel PKCs (μ, δ, ε, η,θ) are Ca2+ independent but are 
regulated by DAG and phosphotidylserine and the atypical (λ, ζ, τ) are onl dependent 
on phosphotidylserine for their activity.The role of these kinases in the endocytosis of 
the GPCRs is know (Namkung et. al., 2004), but the precise role of the different 
families is not been clearly studied. Prolonged stimulation of P2Y receptors results in 
agonist-induced receptor desensitization, but not known is whether this is the direct 
result of receptor internalization, or if it is due to changes in interactions with 
intracellular signaling modulators. Site-directed mutations of probable phosphorylation 
sites of the murine P2Y2 receptor revealed different structural determinants for receptor 
desensitization and sequestration (Garrad et. al., 1998).  
In addition these kinases that are activated upon activation of GPCRs PI3K 
kinase too is know to be activated or mediate the fine tuning of the response of GPCRs. 
In case of beta –2 adrenergic receptor it is know that the activated PI3K is responsible 
for the compartmentalization of the stimulus and modulating the protein kinase-A 
response in cardiac myocytes (Jo et. al., 2002). In addition to the role of clathrin in 
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associating with membrane lipids and the possible role of PI3K has been also postulated 
(Beck and Keen 1991). PI3K has been also implicated to work in close association with 
the actin cytoskeleton (Brachmann et. al., 2005) and to modulate endocytosis and 
transport of vesicles (Merrifield, 2004). In case of the P2Y2 receptor it is known that in 
thyroid cells PI3K is now to modulate the ERK1/2 activation (Elia et. al., 2005). 
In addition to the actin cytoskeleton the PI3K kinase is known to interacts with 
the Rho family of GTPases (Di Marzio, et. al., 2005) The Rho family of GTPases 
belong to a larger family that consist of Ras, Rho/Rac/cdc42,Rab, Sar1/Arf and Ran 
(Bhattacharya et. al., 2005). Rho proteins are known to be involved in modulating the 
trafficking of GPCRs (Sah et. al., 2000). In case of the P2Y2 receptors it is now that it 
does interact with Rho kinases in vascular myocytes and modulate the actin 
cytoskeleton (Sauzeau et. al., 2000). However the direct role of Rho kinases in 
modulating the trafficking of the P2Y2 receptor has not been demonstrated. In addition 
to the whole orchestra of the kinases and cytoskeletal proteins that are necessary for the 
endocytosis of the receptor the lipid content of the plasma membrane does play a role in 
endocytosis of the receptor (Rodal et. al., 1999).  
The phospholipase are known to also modulate the lipd content of the 
membrane. Dynamin a large GTPase whose role in GPCR endocytosis is well 
established (Oakley et. al., 1999). In addition to dynamin, phospholipases have also 
been postulated to play a role in facilitating endocytosis (Shen et. al., 2001). The 
phopspholipases D (PLD) family includes two members namely PLD1 and PLD2. PLD1 
is mainly present at the golgi membranes and the PLD2 is mainly localized at the plasma 
membrane. Both the isoforms are palmitoylated and phosphorylated on Ser/Thr residues 
under basal conditions that help them anchor them to the respective membranes (Exton 
2002).Thus it is reasonable to imagine that the PLD2 is the main isoform that is 
involved in the modulation of endocytosis of GPCRs. The activity of PLDs is 
modulated by the level of intracellular calcium and by PKCs (Siddiqi et. al., 2000). It 
has also been recently shown that PLD2 plays a role in the de and resensitization of the 
mu opiod receptor (Koch et. al., 2004). However the role of the PLD2 in modulating the 
endocytosis of the P2Y2 receptor has not been well studied. 
MAPK are known to be activated on stimulation of GPCRs (Crespo et. al., 1994) 
and growth factor receptor. The MAPK family consists of a series of kinases that are 
sequentially phosphorylated and the last kinase in the series is MAP kinase also known 
as ERK1/2. In case of the P2Y2 receptor too it is know that stimulation of the receptor 
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induces phosphorylation of MAPK in different cell types and leads to proliferation (Hou 
et. al., 1999, Miyagi et.al., 1996, Wilden et. al., 1998). However the effect of MAPK on 
modulating receptor endocytosis and reappearance of the receptor have not been 
directly visualized and studied in detail.  
Dephosphorylation of the endocytosed receptor is one of the steps that form a 
part of the complex process of recycling the receptor back to the plasma membrane. The 
process of recycling the receptor back to the plasma membrane restores the cells ability 
to respond to surface agonists again. Dephosporylation of the receptor is mainly 
mediated via protein phosphatases. Protein phosphatases are divided into 
serine/threonine-specific and tyrosine-specific enzymes, depending on the specificity of 
the residues that they dephosphorylated. They are further subdivided into type-1 (PP1) 
and type-2 (PP2) depending on their specificity for the b and a subunit of phosphorylase 
kinase respectively. The family of PP2 is divided into three subtypes, depending on 
ionic requirements: PP2A (not dependent on metal ions for activity); PP2B (calcineurin, 
Ca2+-calmodulin-dependent) and PP2C (Mg2+ or Mn2+ dependent) (Fernandez et. al., 
2002). The role of PP2A has mainly been studied in the modulation of cellular 
proliferation and thus as a potential taget for anti-cancer therapy, however its role in 
vesicle trafficking (Guatimosim et. al., 2002) and modulation of receptor endocytosis 
(Runnwgar et. al., 1997) has not been extensively studied. 
In addition to the nucleotide triphosphates another class of molecules namely 
dinucleotide polyphosphates have been also postulated to function via the P2Y 
receptors. Dinucleoside polyphosphates have been discovered in the late 60’s as 
probable signaling molecules (Zamecnik and Stephenson, 1969), but it was not till 1976 
that their putative physiological role in modulating the proliferation of mammalian cells 
was demonstrated (Rapaport and Zamecnik, 1976). The most ubiquitous of the 
dinucleotide polyphosphates and the most studied are the diadenosine polyphosphates. 
The naturally occurring diadenosine polyphosphates are Ap2-7A. These diadenosine 
polyphosphates exhibit a large number of physiological effects ranging like modulation 
of vascular tone(Schlüter et. al.,1998),function of KATP channels (Jovanovic et. al., 
1996), glycealdehyde -3-phosphate dehydrogenase activity (Filonenko et. al., 1989), 
release of neurotransmitters like acetylcholine(McLennan et. al., 2000) and intracellular 
pH (Schulte et. al., 1999). Diadenosine polyphosphates have been also known to 
modulate the proliferation of different cells types like renal mesangial (Schulze-Lohoff, 
1995). In spite of the large physiological functions that have been attributed to the 
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diadenosine polyphosphates it is till now always debatable if these substances act via 
their own class of receptors (Pintor et. al., 2000) or do they signal via the P2Y receptors 
(Laubinger et. al., 2003).  
However, little is known about the pathways involved in P2Y2 receptor 
trafficking. In addition to this there is also little evidence to the role of the diadenosine 
polyphosphates in modulating the trafficking of the P2Y2 receptor and their role in 
modulating proliferation via the P2Y2 receptor. Thus, we decided to investigate the 
trafficking of the P2Y2 receptor and its interaction with intracellular compartments and 
the cytoskeleton to elucidate the subcellular localization of the P2Y2 receptor upon 
agonist stimulation. 
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1.2. Aims of this study: 
The cell system that we used for this study is Human embryonic kidney cells 
(HEK 293). These cells were chosen as an expression system for the P2Y2 receptor as 
these cells do endogeneously express the P2Y receptors. This system thus provides a 
good model fro studying the trafficking of the receptor as the entire machinery for 
receptor trafficking is present in the cell. 
The main aims of this study are: 
1) Functional expression of the P2Y2 receptor tagged to either GFP or 
the myc-His tag. 
2) To investigate the factors that modulate the trafficking of the receptor 
and possible proteins that might be involved in the trafficking of the 
receptor. 
3) To determine the role of different kinases in modulating the 
trafficking of the receptor. 
4) To investigate if the diadenosine polyphosphates activate the P2Y2 
receptor and modulate its traficking. 
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2 MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Lab instruments and materials 
Applied Biosystems divisions: ABI PRISMTM 310 Genetic analyzer 
(Foster city, CA, USA) 
Biometra :     T3 Thermocycler 
(Göttingen, Germany) 
Bio-Rad :    Electrophoresis power supply 
     Gel electrophoresis system 
     Semi-dry transfer cell 
Carl Zeiss :    LSM510meta Confocal laser scanning microscope 
(Jena, Germany)                                 Axiovert 135 fluorescence microscope 
Eagle Eye : Still video system 
(Stratagene, Heidelberg, Germany) 
Eppendorf :  Thermomixer comfort 
Heraeus : Biofuge A, 13 R, 3.2 RS (centrifuge) 
 LaminAir® (clean bench) 
 Cell culture incubator 
Molecular devices :  Microplate reader 
Pharmacia Biotech : UV/visible spectrophotometer 
Tecan :  Genios plus (microplate reader) 
(Berlin, Germany) 
TILL Photonics : Ca2+ imaging system 
(Munich, Germany) 
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2.1.2 Chemicals 
Alexis : Pertussis toxin (PTX) 
(San diego, CA, USA) 
Amersham Pharmacia Biotech : ECL plus (western blotting detection 
system) 
Applied Biosystems : DNA sequencing kit 
(Warrington, UK) 
 
BD Transduction: Anti Clathrin heavy chain antibody, Anti Early 
endosome antigen (EEA-1), Anti lysosome 
associated marker protein-1 (LAMP-1) 
Calbiochem : FTI-277, KN62, G 418, GÖ6976, GF 109203X, 
GÖ6983, ML-9, MG-132, U73122, Y-27632, 
Wortmannin,  
Carl Zeiss: ImmersolTM 518N (Immersion oil for microscopy) 
(Jena, Germany) 
Clontech: pEGFPN2 (enhanced green fluorescencent protein 
expression vector) 
Gibco/BRL DNA purification kit 
Invitrogen: pcDNA 3.1 A(+) myc-His, anti myc antibody 
(Groningen, Netherland) 
Molecular Probes: Cholera toxin subunit  B coupled to Alexa Fluor 
555, Fura-2/AM, goat anti mouse antibody coupled 
to Alexa fluor 555, Lyso tracker Red and Phallodin 
coupled to Alexa Fluor 546 
Quiagen     DNA Mini/Midi preperation kit 
Roche Molecular Biochemicals : Cell Proliferation ELISA BrdU  
(Mannheim, Germany)  (cheminuminiscence) kit, DOTAP 
Sigma-Aldrich: ATP, chlorpromazine, cytochalasin-D (Cyto-D), 
filipin-III, UTP 
(Deisenhofen, Germany) 
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2.1.3 Buffer and Solvent 
 All buffers were prepared with distilled water. 
2.1.3.1 Cell culture medium and solvents 
DMEM : 3.7 g/L NaHCO3, 4.5 g/L D-glucose, 1.028 g/L N-Acetyl 
L-alanyl-L-glutamine 
HAM’S F-12 : 1.17 g/L NaHCO3; 1.802 g/L D-glucose, 0.146 g/L L-
glutamine 
 
2.1.3.2 Buffer 
1x HBSS : 145 mM NaCl, 5.4 mM KCl, 1mM MgCl2, 1.8 mM CaCl2, 
25 mM glucose, 20 mM HEPES, pH 7.4 adjusted with 
1.67 M Tris (hydroxymethyl)-aminomethane 
1x Ca2+ free HBSS: 120 mM NaCl, 5 mM KCl, 1mM MgCl2, 25 mM glucose, 
2mM Na2HPO4, 20 mM HEPES, pH 7.4 
1x PBS: 137 mM NaCl, 2.6 mM KCl, 8.1 mM Na2HPO4, 1.4 mM 
KH2PO4 
2.2 Methods 
2.2.1 Cell Culture 
The HEK 293 cells were grown in medium consisting of DMEM/Ham’s-F12 
(1:1), supplemented with 10% fetal calf serum, 100 IU/ml penicillin and 100 IU/ml 
streptomycin (referred to in subsequent text as culture medium) in a 5% CO2/95% air, 
humidified atmosphere at 37°C (Vöhringer, et.al.,2000). 
2.2.2 Subcloning of the P2Y2 receptor DNA 
The rP2Y2 receptor cDNA was kindly provided by Dr. Rice (Rice et. al., 1995 ) 
The DNA that we received was subcloned from pBK-CMV-P2Y2 to pcDNA3.1A(+) 
Myc-His (Invitrogen) and pEGFPN2 (Clontech). The original vector was digested with 
EcoRI and XhoI or EcoRI and BamH-I to obtain DNA fragment encoding for the P2Y2 
receptor. The fragments that were obtained were ligated into the linearized Myc-His and 
EGFP vectors respectively. The ligated product was purified using the DNA 
purification kit from Gibco/BRL. The purified DNA was checked for the presence of 
the inset by digestion of the ligated DNA using EcoR-I and BamH-I. The successfully 
ligated DNA constructs were transformed into E.coli using the potassium chloride 
method. The E.coli were plated and allowed to grow for 24 hours at 370C on LB-agar 
plates containing 100 mg/ml ampicilin, as a selection marker. The positive clones were 
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picked , and cultivated in 5 ml of LB medium containing ampicilin for 24 hours. DNA 
was prepared form the above cultures using the DNA-Mini-prep kit (Qiagen). The DNA 
obtained from the mini prep was digest with EcoR-I and BamH-I to recheck for the 
presence of the inset of the DNA encoding P2Y2 receptor with the appropriate tag. The 
DNA from the positive clones was sequenced using the DNA sequencing kit from ABI 
PRISM., using the following set of primers: 
P2Y2 forward-1: GGT GGC GTT GCC TTA GAT AC, P2Y2 reverse-1: CCC CCT 
CCC AGG TGC CAT TG, P2Y2 forward-2: CGC AGT ACA AGG GCT GGG AG, 
P2Y2 reverse-2: CCT GCA TCA GCG TGC ACC GG and P2Y2 forward-3 : CGC TTT 
GCC CGA GAT GCC AAG CC.  
 The clones that expressed the complete P2Y2 receptor with the appropriate tag 
without any point mutations and frame shift, were retransformed in E.coli using the 
potassium chloride method, and the DNA was isolated using the DNA Midi-Prep kit 
(Qiagen). 
2.2.3 Transfection and selection of cells 
The rP2Y2 receptor DNA was subcloned into pcDNA 3.1A(+) myc-his (MH) 
(Invitrogen) and pEGFPN2 (Clontech). Transfection of HEK 293 cells was carried out 
as described previously (Vöhringer, et.al.,2000) Briefly, HEK 293 wild-type cells were 
transfected with 5 µg/ml DNA in serum-free medium using DOTAP for 8 h. After this 
time, the medium was replaced with complete medium and the cells were selected with 
1 mg/ml G418. Transfected cells were grown in medium consisting of DMEM/Ham’s-
F12 (1:1), supplemented with 10% fetal calf serum, 100 IU/ml penicillin and 100 IU/ml 
streptomycin in a 5% CO2/95% air, humidified atmosphere at 37°C. 
2.2.4 Cytosolic Ca2+ measurements 
The cells were plated on PLL-coated plates and single cell measurements were 
made after 3 days, when the cells were 40-60% confluent. The changes in free 
intracellular Ca2+ concentration ([Ca2+]i) were measured by preincubation of the cells 
with 2 μM Fura-2AM for 30 min in NaHBS (HEPES buffered saline solution: 145 mM 
NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 25 mM glucose and 20 mM 
HEPES/Tris pH 7.4). Then cells were stimulated under continuous superfusion of pre-
warmed NaHBS at 37°C with different concentrations of UTP or other agonists at 37°C. 
Fluorescence intensity was recorded alternatively at 340 nm and 380 nm excitation and 
520 nm emission. Changes were monitored in single cells bathed in a perfusion 
chamber which was placed on the microscope stage (Zeiss) of a fluorescence imaging 
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system from TILL Photonics with a 40X oil immersion objective and a flow rate of 1 
ml/min (Vöhringer, et.al., 2000). 
2.2.5 Live cell imaging  
The cells were plated at a density of 5 × 105 to 1 × 106 cells/dish on poly-L-
lysine (0.01%)-pre-coated coverslips (Ø =30 mm). The cells were stimulated with 100 
µM UTP in medium in a 5% CO2/95% air, humidified atmosphere at 37°C. Lysosomes 
were labeled by preincubating the cells for 30 min with 100 nM LysoTracker Red 
(Molecular Probes) prior to agonist stimulation. The cells were pre-incubated for 30 min 
with the appropriate concentration of the inhibitor, to investigate the role of specific 
proteins in the modulating the trafficking of the receptor.  
2.2.6 Agonist-induced internalization 
The cells were plated at a density of 5 × 105 to 1 × 106 cells/dish (Ø = 50 mm) 
on poly-L-lysine (0.01%)-pre-coated coverslips (Ø =22 mm). The cells were stimulated 
with 100 µM ATP or UTP in medium at 37°C. Labeling of other subcellular 
compartment markers such as LAMP-1 (lysosomes), and EEA-1 (early endosomes) was 
performed in fixed cells by immunofluorescence, as described below.  
2.2.7 Cell staining for immunofluorescence 
Immunohistochemistry was performed as suggested by the manufacturer 
(Pharmingen Heidelberg, Germany). Briefly, cells grown on coverslips were fixed using 
methanol:acetone (1:1) for 10 min at -200C after agonist stimulation. The cells were 
then placed in blocking buffer (1% bovine serum albumin (BSA) in phosphate buffered 
saline (PBS) for 1 h. Cells were then incubated with primary antibody (e.g., anti-clathrin 
heavy chain, anti-EEA-1, anti-LAMP-1, or anti-myc antibody) in blocking buffer for 1 
h at room temperature, washed three times in PBS and incubated with Alexa Fluor 568 
secondary antibody in blocking buffer for 1 h at room temperature. The cells were then 
washed three times in PBS and the coverslip was inverted onto a slide covered with 
mounting medium. For F-actin staining, the cells were stimulated with agonist, fixed as 
above, and incubated for 10 min with phalloidin-Alexa Fluor 546. The cells were then 
washed three times with PBS and the coverslip was placed onto a slide and covered 
with mounting medium.   
2.2.8 Confocal imaging 
Images were taken on a Zeiss inverted LSM 510 laser scanning confocal 
microscope equipped with a Plan-Apochromat 63X objective. The GFP was excited 
using a 488 nm argon/krypton laser, and the emitted fluorescence was detected with a 
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505-530 band pass filter. LysoTracker Red and Alexa Fluor 555/568 were detected 
using a 543 nm helium/neon laser for excitation and a 560 nm long pass filter. In live-
cell imaging, the cells were incubated on stage in a chamber of 5% CO2 at 37°C in 
complete culture medium. Images were processed with Zeiss confocal microscopy 
software, release 3.2. The amount of receptor that was endocytosed by stimulation of 
the cells with agonist was quantified by measuring the change in fluorescence intensity 
at the plasma membrane and in the cytoplasm. A three channel (green, red and 
transmission) simultaneous measurement was performed at each time point for the 
figures indicated, which also included a Z-scan. Green fluorescence detected the P2Y2 
receptor coupled to GFP and the red fluorescence detected the lysosomes in the 
cytoplasm. The Z-scan was used to detect the upper plasma membrane via an overly 
between the transmission picture and the GFP channel. The exact position of the lower 
plasma membrane can be also determined, but only changes in the upper plasma 
membrane were considered. The position of the ROIs for the plasma membrane was 
adjusted for every time point with reference to the transmission picture to encompass 
the plasma membrane and not the cytoplasm. To confirm that the ROI on the plasma 
membrane did not encompass minimal or any of the cytoplasmic regions a 
colocalization analysis was done between the green and the red channel (Weisshart et. 
al., 2004). The calculations took into consideration the relative intensities of the pixels 
in the respective ROI and the value obtained was the mean of the fluorescence 
intensities of the pixels in the ROIs.  
2.2.9 Cell Proliferation ELISA by 5-bromo-2’-deoxyuridine (BrdU) 
incorporation 
This technique is based on the incorporation of the pyrimidine analogue BrdU 
instead of thymidine into the DNA of proliferating cells. After its incorporation into 
DNA, BrdU is detected by an immunoassay method using a kit from Roche.  
HEK 293 cells stably expressing the rP2Y2-GFP receptor or untransfected HEK 
293 cells were plated at a density of 5 X 103 cells per well in 96-well plates. The cells 
were stimulated 24 h after plating them, with the respective test substances in an 
appropriate 96-well plate at 37°C for one hour. In case of pre-incubation with inhibitors, 
the incubators were added one hour before stimulation with the appropriate test 
substance. Subsequently, BrdU is added to the cells and the cells are reincubated 
(usually 15 h). During this labeling period, the pyrimidine analogue BrdU is 
incorporated in place of thymidine into the DNA of proliferating cells. After removing 
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the culture medium, the plate was dried at 600C for 1.5 hours and then the cells are fixed 
and the DNA is denatured in one step by adding FixDenat (the denaturation of the DNA 
is necessary to improve the accessibility of the incorporated BrdU for detection by the 
antibody). The anti-BrdU-peroxidase antibody binds to the BrdU incorporated in newly 
synthesized, cellular DNA. The immune complexes are detected by the subsequent 
substrate reaction. 
 
2.2.10 Data analysis 
Unless stated otherwise, results are presented as mean ± S.E.M., and statistical 
analysis was achieved by Student's unpaired t test using SigmaPlot (Jandel Scientific, 
Erkrath, Germany). 
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3. RESULTS: 
3.1 Functional expression of GFP- and MH-tagged P2Y2 
receptors in HEK-293 cells 
The P2Y2-GFP receptor was directly visualized in live cells using a confocal 
laser scanning microscope (Fig. 3.1A). The receptor was localized mainly at the plasma 
membrane of the cells and not concentrated in any other cellular compartment. We also 
expressed the P2Y2 receptor with a myc-his (MH) tag which was detected by 
immunostaining of fixed cells with anti-myc antibody as primary antibody and Alexa 
Fluor 488-conjugated secondary antibody. The myc-his tagged P2Y2 receptor was 
similarly detected at the plasma membrane of the cells (Fig. 3.1B). Thus, incorporation 
of either the GFP or MH tag at the C-terminus of the P2Y2 receptor did not prevent the 
targeting of the receptor to the plasma membrane.  
BA  
 
 
 
 
 
Figure 3.1: Stable expression of rP2Y2 receptor in HEK-293 cells. 
(A) HEK 293 cells were transfected with the DNA rP2Y2GFP by the lipofection 
method. The expression of the receptor was visualized using the CLSM. The stably 
expressed receptor is found to be exclusively localized on the plasma membrane. This 
localization is similar to the endogenously expressed P2Y2 receptor. (B) HEK 293 cells 
transfected with rP2Y2MH. The expression pattern of the receptor was conformed in 
stably transfected cells by immunohistochemistry using anti-myc and Alexa Fluor 488. 
Scale bar 20 µm. 
 
Functional coupling of the transfected P2Y2-GFP receptor was determined by 
measuring the changes in the concentration of intracellular free Ca2+ ([Ca2+]i)in fura-2 
loaded cells upon stimulation with P2Y2 receptor agonists. Transfected and 
untransfected cells were challenged with the nucleotide agonists UTP or ATP, at 
different concentrations ranging from 10-9 M to 10-4 M. The cells were visualized at 340 
nm to monitor changes in [Ca2+]i by fura-2 fluorescence and at 460 nm to detect the 
P2Y2-GFP receptor. The simultaneous visualization of fura-2 and GFP fluorescence 
allowed the selection of double-positive, transfected cells with high receptor expression 
level for measurement of the Ca2+ response. In untransfected cells the calcium response 
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to nucleotide is due to stimulation of endogeneous P2Y2 and P2Y1 receptors, since 
mRNAs for these receptors were previously detected in HEK-293 cells by reverse 
transcriptase-polymerase chain reaction (RT-PCR) (Schäfer et. al.,2003; Vöhringer et. 
al., 2000). In untransfected cells, the agonist-induced calcium response was submaximal 
at agonist concentrations below 10-5 M, and at 10-7 M there was only a negligible 
response. The EC50 value for either UTP or ATP in untransfected cells was 1.8 µM. In 
P2Y2-GFP receptor transfected cells, the sensitivity of the cells to the agonist was 
increased, as observed from the leftward shift of the curves in comparison to 
untransfected cells. The EC50 values for nucleotides in cells expressing the rP2Y2-GFP 
receptor or the rP2Y2-MH receptor, respectively, were 200 nM and 350 nM for UTP, 
and 200 nM and 150 nM for ATP (Fig 3.2, A and B). These results confirm that the 
tagged receptors were functional when expressed in HEK-293 cells.  
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Figure 3.2 : Functional expression of the transfected rP2Y2 receptor  in HEK 293 
cells. 
The stably transfected HEK 293 cells expressing either rP2Y2-GFP (triangles) or 
rP2Y2myc-his (squares) were grown in serum-containing medium. For measurement the 
cells were preloaded with fura-2A and then perfused with NaHBSS containing Ca2+ and 
stimulated for 1 min with different concentrations of UTP (A) or ATP (B) The 
untransfected cells (circle) were stimulated with the same concentrations of agonists as 
control. The data are from single cell Ca2+ recordings and represent the mean ± S.E. for 
at least 50 cells for each value.  
 
3.2 Effect of agonist concentration on receptor localization  
The rP2Y2-GFP receptor expressed in HEK-293 cells was stimulated with UTP, 
an agonist of the P2Y2, but not the P2Y1 receptor. In unstimulated cells, the receptor 
was localized mainly to the plasma membrane (Fig. 3.1A). Stimulation of rP2Y2-GFP 
receptor transfected cells with 1-100 µM UTP resulted in a concentration-dependent 
increase in the extent of receptor internalization. This was observed as a loss of 
receptor-associated fluorescence from the plasma membrane and the simultaneous 
accumulation of fluorescence in intracellular organelles (Fig. 3.3 B-D). The increase in 
the amount of internalized receptor is indicated by bold arrows (Fig. 3.3 B-D). The loss 
of fluorescence from the plasma membrane was determined by quantitating the 
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fluorescence intensity in user-defined regions of interest (ROI) that encompass either 
the plasma membrane or cytoplasmic regions. As shown in Fig. 3.3E, at 100 µM UTP 
there was almost no receptor left at the plasma membrane but it appeared entirely in the 
cytoplasmic compartment. Qualitatively similar results were obtained for internalization 
of the rP2Y2-MH receptor (data not shown), indicating that the presence of either a GFP 
or myc-his tag did not affect receptor internalization. In our further studies of receptor 
endocytosis we used the agonist UTP at 100 µM, because this concentration induced 
complete receptor endocytosis and the amount of receptor present at the plasma 
membrane and in the cytoplasm could be clearly distinguished. 
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Figure 3.3: Stable expression of the rP2Y2 receptor in HEK-293 cells and agonist 
concentration-dependent internalization of the rP2Y2-GFP receptor. 
Stable expression of the rP2Y2 receptor in HEK-293 cells and agonist concentration-
dependent internalization of the rP2Y2-GFP receptor. (A–D) HEK-293 cells were stably 
transfected with cDNA encoding the rP2Y2-GFP gene, as described in Materials and 
methods. Expression and localization of the receptor were visualized in live cells using 
confocal laser scanning microscopy (CLSM). The rP2Y2-GFP receptor was visualized 
in stably transfected HEK-293 cells that were unstimulated (A, control cells), or 
stimulated for 30 min at 37°C with 1 µM (B), 10 µM (C) or 100 µM UTP (D). The 
increase in the amount of internalized receptor is indicated by bold arrows. Scale bar, 20 
µm. (E) The fluorescence intensity at the plasma membrane and in the cytoplasm was 
calculated by selecting the appropriate region of interest, using Zeiss software. The 
distributions of cellular fluorescence intensity between the cytoplasm (hatched bars) and 
the plasma membrane (open bars) were determined in unstimulated and stimulated cells. 
The data are normalized to initial fluorescence intensity at the plasma membrane 
(100%). The data presented are the means ± SD from at least three independent 
experiments with 20 cells each. 
 
3.3 Compartmentalization of the receptor after stimulation 
with agonist  
The agonist-promoted loss of surface immunoreactivity in cells expressing the 
P2Y2 receptor has been investigated previously (Sromek et. al.,1998), but the time 
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dependent compartmentalization of the P2Y2 receptor and the mechanism responsible 
for internalisation have not yet been investigated. HEK-293 cells stably expressing 
rP2Y2-GFP receptors were stimulated with 100 µM UTP for 30 or 60 min. In these 
experiments, after stimulation, the cells were fixed and incubated with antibodies raised 
against either the early endosome antigen–1 (EEA-1) (Mills et. al., 1998) or the 
lysosomal associated membrane protein-1 (LAMP-1). After 30 min with UTP, the 
internalized receptors (green) colocalized with early endosomes (red) (colocalization 
shown by yellow, and indicated by arrows in Fig. 3.4, A3, but not with lysosomes (data 
not shown). After 60 min with UTP, P2Y2-GFP receptors colocalized with lysosomes 
(red), as indicated by the yellow signal and indicated by arrows in Fig. 3.4, A6, but were 
no longer detected in early endosomes (data not shown).  
Lysosomal localization of P2Y2-GFP receptors after stimulation with UTP for 
60 min was seen in fixed cells (Fig. 3.4, A6). A similar colocalization was obtained 
when the cells were cells pre-loaded with Lyso Tracker were exposed to 100 µM UTP 
for 60 min (see large yellow structure in Fig. 3.9B indicated with bold arrow). This 
experiment thus confirmed the above immunohistochemistry results.  
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Figure 3.4 (A): Compartmentalization of the receptor after stimulation with 
agonist.  
Colocalization of the rP2Y2-GFP receptor with early endosomes and lysosomes after 
UTP stimulation. HEK-293 cells stably expressing the rP2Y2-GFP receptor were 
stimulated with 100 μM UTP at 370C in culture medium for 30 min (A1) or 60 min 
(A4). Colocalization of the GFP-tagged receptor (green) with early endosomes or 
lysosomes was determined in fixed cells with mouse anti-EEA-1 antibody (A2; red) or 
anti-LAMP-1 antibody (A5, red), respectively, visualized with goat anti-mouse Alexa 
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Fluor 568 as secondary antibody. Colocalization is indicated in yellow (A3, A6), 
marked with arrows. Scale bar shown for each figure is 20 µm. Results shown are 
representative of at least 3 individual experiments.  
 
Farnesylation of endosomal proteins is important in trafficking of the receptors 
from early endosomes and deciding the trafficking of the receptor. So we investigated if 
this factor affects the trafficking of the P2Y2 receptor. Cells were preincubated for 30 
min with 100 nM LysoTracker red to label lysosomes and 10 µM farnesyltransferase 
inhibitor FTI-277. This inhibitor blocks farnesylation of endosomal proteins and 
prevents trafficking of internalized membrane proteins between endosomes and 
lysosomes (Doisneau-Sixou et.al.,2003). Preincubation of the cells with FTI-277 did not 
affect the localization of the rP2Y2-GFP receptor (Fig. 3.5, A1) and did not prevent the 
UTP-induced endocytosis of the receptor (Fig. 3.5, A2). However, FTI-277 prevented 
the colocalization of internalized receptors with lysosomes stained with LysoTracker 
red, even after 60 min of UTP stimulation (Fig. 3.5, A3), a time normally sufficient to 
target the rP2Y2-GFP receptor to lysosomes (Fig. 3.4, A6).  
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Figure 3.5: Effect of the farnesyltransferase inhibitor FTI-277 on trafficking of the 
rP2Y2-GFP receptor.(also in Tulapurkar et. al., 2005). 
Effect of the farnesyltransferase inhibitor FTI-277 on trafficking of the rP2Y2-GFP 
receptor by live cell imaging. HEK-293 cells expressing the rP2Y2-GFP receptor were 
preincubated with 100 nM LysoTracker (red fluorescence) and 10 µM FTI-277 for 30 
min at 37°C. Cells were unstimulated (A1), or stimulated with 100 µM UTP for 30 min 
(A2) or 60 min (A3) and receptors and lysosomes were visualized. FTI-277 prevents 
colocalization of the the internalized receptor with lysosomes. The results shown are 
representative of 3 different experiments. Scale bar of 20 µm. 
 
3.4 UTP induced actin cytoskeletal rearrangements  
Rearrangements of the cytoskeleton play an important role in cellular processes 
such as endocytosis and exocytosis (Qualmann et. al., 2000). Stimulation of HEK-293 
cells expressing the rP2Y2-GFP receptor with 100 µM UTP caused massive 
reorganization of the actin cytoskeleton counterstained in fixed cells with Alexa Fluor 
546-labeled phalloidin (red). In unstimulated cells the rP2Y2-GFP receptor and actin 
were colocalized to the plasma membrane with few actin fibers in the cytoplasm (Fig. 
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3.6, A2) indicating that the cells were not under stress (Giancotti, et.al., 1999). For the 
first 5 min of UTP stimulation, the rP2Y2-GFP receptor remained localized to the 
plasma membrane, whereas actin was redistributed to the cytoplasm (Fig. 3.6 B 1,2). 
After 10 min of UTP stimulation, initial receptor internalization was observed and actin 
was diffusely distributed in the cytoplasm (Fig. 3.6, C1,2). In case of Fig. 3.6 B3, it is 
seen that there is no colocalization of actin with the receptor in comparison to 3.6 A3, 
and a diffuse staining of actin is seen. This demonstrates that actin rearrangement 
preceded endocytosis of the receptor. After 20 min of UTP stimulation, only 20% of the 
receptors remained at the plasma membrane, as compared to unstimulated cells, 
whereas actin had redistributed to the plasma membrane (Fig. 3.6, D1,2). The rP2Y2-
GFP receptor was completely internalized at 30 min (data not shown), and 60 min after 
UTP stimulation, whereas actin reappeared concentrated at the plasma membrane (Fig. 
3.6, E1,2).  
Figure 3.6: Actin cytoskeleton rearrangement in UTP-stimulated HEK-293 cells 
expressing the rP2Y2-GFP receptor. HEK-293 cells expressing the rP2Y2-GFP 
receptor were incubated in culture medium at 37°C in the absence (A) or presence (B–E) 
of 100 µM UTP for 5 (B) 10 (C), 20 (D) or 60 (E) min. The cells were then fixed and 
counterstained with actin-binding phalloidin coupled to Alexa Fluor 546 (as described 
in Materials and methods) and actin (red) and rP2Y2-GFP receptor (green) were 
visualized. In A to E, the respective picture with number 1 represents green fluorescence 
of P2Y2-GFP receptor, the picture with number 2 represents red fluorescence of actin 
staining, and the picture with number 3 gives the overlay. Colocalization of actin and 
rP2Y2-GFP receptor is indicated in yellow. Scale bar, 20 µm. Results shown are 
representative of at least three individual experiments. 
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To confirm the role of actin cytoskeleton in receptor endocytosis, HEK-293 cells 
expressing the rP2Y2-GFP receptor were pretreated with an actin-disrupting agent, 
cytochalasin-D (Sergeeva M., et.al., 2000), prior to UTP stimulation. Fig. 3.7 indicates 
that a 30 min treatment with UTP was insufficient to induce receptor internalization in 
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cytochalasin-D-treated cells (Fig. 3.7, A2), whereas the receptor was completely 
internalized by a 20 min treatment with UTP in the absence of cytochalasin-D, as seen 
above in Fig. 3.6 D1. As compared to unstimulated cells (Fig. 3.6 A1), a 30 min 
stimulation with UTP, induced a punctate receptor distribution in the membrane (Fig. 
3.7, A2). In cytochalasin-D-treated cells stimulated with UTP for 60 min, the receptor 
was internalized in small vesicles (Fig. 3.7, A3), in contrast to the large receptor 
aggregates internalized in cells treated with UTP in the absence of cytochalasin-D (Fig. 
3.1D).  
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Figure 3.7: (A) Effect of actin disrupting agent cytochalasin-D, on endocytosis of 
the rP2Y -GFP receptor. 2
(A) HEK-293 cells stably expressing the rP2Y2-GFP receptor were preincubated with 
100 nM cyto-D at 37 °C for 30 min and live-cell confocal imaging was performed. 
Images were collected from cells before stimulation (A1), and stimulated with 100 µM 
UTP for 30 min (A2) or 60 min (A3). Scale bar, 20 µm. Results shown are 
representative of at least three individual experiments. 
 
We next examined the effect of the myosin light chain kinase inhibitor, ML-9 
(Kawamura M., et. al., 2003), on P2Y2 receptor internalization. Myosin is a small 
ATPase whose activity is important for the normal reorganization of the actin 
cytoskeleton. Myosin light chain kinase modulates the function of myosin by 
phosphorylation of specific residues. Thus, we decided to investigate the role of a subtle 
modulatory protein on the trafficking of the P2Y2 receptor. HEK-293 cells expressing 
the rP2Y2-GFP receptor were preincubated with 100 µM ML-9 and 100 nM 
LysoTracker Red for 30 min and then stimulated with 100 µM UTP. In comparison to 
the membrane localization of rP2Y2-GFP receptors in ML-9-treated controls (Fig. 3.8, 
A1), a 30 min UTP stimulation in the presence of ML-9 induced receptor localization 
(green) in small vesicular clusters below the plasma membrane (marked by arrows in 
Fig. 3.8, A2), which is different from the effect of cytochalasin-D in UTP-treated cells 
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(Fig. 3.7, A2). For three-dimensional analysis, YZ- and XZ-images were constructed 
from XY-plane images, which were taken from the bottom to the top of each cell. The 
presence of the vesicles, as indicated by arrows in Fig. 3.8 A2, just below the plasma 
membrane is visible in these X-Z and the Y-Z projections. After a 60-min UTP 
stimulation in the presence of ML9, receptor endocytosis had occurred although there 
was little localization of receptor in lyososmes (red) in Fig. 3.8, A3, in contrast to 
results in the absence of ML-9 (cf. data for fixed cells shown in Fig. 3.4, A6). Taken 
together, these findings indicate that the actin cytoskeleton and cytoskeletal-associated 
proteins (e.g., myosin) mediate the endocytosis of the rP2Y2-GFP receptor.  
 
A1 A3 
A2 
Y-Z 
projection
X-Z  
projection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: Role of myosin light chain kinase, in endocytosis of the rP2Y2-GFP 
receptor. HEK-293 cells expressing the rP2Y2-GFP receptor were preincubated with 
100 µM ML-9 and 100 nM LysoTracker Red for 30 min at 37 °C and then live-cell 
imaging was performed. Images were collected from cells before stimulation (A1), and 
stimulated with 100 µM UTP for 30 min (A2) or 60 min (A3). In ML-9-treated cells, 
the receptor was clustered upon UTP treatment in small vesicles below the plasma 
membrane (arrows in A2). This is clearly visible in the X-Z and Y-Z projections. There 
was no colocalization of the endocytosed receptor with lysosomes (as seen in A3). Scale 
bar, 20 µm. Results shown are representative of at least three individual experiments. 
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3.5 Inhibition of receptor internalization  
UTP-mediated rP2Y2-GFP receptor internalization in HEK-293 cells was 
completely inhibited at 4°C (data not shown). In addition, there was very little receptor 
internalization at 14°C or 28°C (data not shown), indicating that P2Y2-GFP receptor 
endocytosis is temperature-dependent. The temperature effect indicates that there is no 
constitutive endocytosis of the receptor. 
P2Y2 receptor endocytosis was also sensitive to the density of the medium, since 
addition of 0.45 M sucrose prevented UTP-induced receptor internalization (data not 
shown), and after a 30 min UTP stimulation most of the receptor remained localized to 
the plasma membrane in small punctate structures (data not shown). The inhibition of 
endocytosis of the receptor by 0.45 M sucrose suggests the role of clathrin-dependent 
mechanism (McArdle et. al., 2002).  
3.6 Colocalization of the P2Y2 receptor and clathrin 
Unstimulated cells displayed a diffuse distribution of clathrin (red) in the 
cytoplasm, and the receptor (green) was localized to the plasma membrane (Fig. 3.9, 
A1,2). After a 10 min UTP stimulation, colocalization of the internalized receptor and 
clathrin was first detected (Fig. 3.9, B3). After a 20 min UTP stimulation, most of the 
receptor signal colocalized with clathrin (Fig. 3.9, C3). Interestingly, rP2Y2-GFP 
receptor and clathrin colocalization was no longer detectable after 30 min UTP 
stimulation (data not shown). Thus, these results strongly suggest that UTP-dependent 
endocytosis of the P2Y2-GFP receptor occurs via clathrin-coated pits, prior to receptor 
transport to early-endosomes or lysosomes depending on the duration of agonist 
exposure.  
 
Figure 3.9: UTP induces colocalization of the rP2Y2-GFP receptor with clathrin. 
HEK-293 cells expressing the rP2Y2-GFP receptor were incubated in the absence (A) or 
presence (B, C) of 100 µM UTP at 37 °C for 10 min (B), or 20 min (C). The cells were 
fixed, immunolabeled with mouse monoclonal anti-clathrin antibody and with goat anti-
mouse Alexa Fluor 568 as secondary antibody, and images were collected. The receptor 
is visualized by green fluorescence, the clathrin by red fluorescence. The pictures 
numbered 1, 2 and 3 in A to C show P2Y2-GFP receptor in 1, clathrin staining in 2, and 
the overlay in 3. Colocalization is indicated by yellow. Scale bar, 20 µm. Results shown 
are representative of at least three individual experiments. 
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To confirm the involvement of a clathrin-mediated pathway in agonist-induced 
P2Y2-GFP receptor endocytosis, cells were preincubated with 100 µM chlorpromazine, 
an inhibitor of clathrin-mediated endocytosis (Petris et. al., 2003), and then stimulated 
with 100 µM UTP for 30 min. Chlorpromazine by itself did not affect cell shape or 
P2Y2-GFP receptor distribution in the absence of UTP (Fig. 3.10, A1), but it prevented 
UTP-induced receptor internalization (Fig. 3.10, A2). When cells were preincubated 
with 100 µM chlorpromazine for 30 min and 5 nM cholera toxin subunit-B coupled to 
Alexa Fluor 555, a marker for the caveolin-rich lipid rafts in the plasma membrane 
(Orlandi et. al., 1998), the rP2Y2-GFP receptor colocalized with cholera toxin subunit B 
in unstimulated cells (Fig. 3.10, A3). After a 30 min stimulation with 100 µM UTP, 
neither receptor endocytosis nor redistribution of cholera toxin was detected (Fig. 3.10, 
C3), indicating that inhibition of clathrin-mediated endocytosis by chlorpromazine does 
not lead to P2Y2-GFP receptor internalization by the caveolin-mediated pathway. 
Cholera toxin internalization is known to occur by a caveolin-mediated pathway. 
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However, cholera toxin was not internalized upon activation of the P2Y2-GFP receptor 
in HEK-293 cells. Therefore, P2Y  receptors apparently do not couple to this pathway.  2
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Figure 3.10: Effect of chlorpromazine and cholera toxin on internalization of the 
rP2Y -GFP receptor. 2
HEK-293 cells expressing the rP2Y2-GFP receptor were preincubated with 100 µM 
chlorpromazine alone (A1) or together with 5 nM cholera toxin subunit B coupled to 
Alexa Fluor 555 (B) for 30 min at 37 °C. The cells were then incubated for 30 min at 
37°C in the presence of 100 µM UTP (A2 and C), and images were collected. The 
numbering of pictures in B and C depicts, P2Y2-GFP receptor (green fluorescence) in 1, 
cholera toxin subunit B staining (red fluorescence) in 2, and the overlay in 3. Cells that 
are shown in B and C are the same set of cells. Those depicted in (B) are before and (C) 
after incubation with UTP. Scale bar is 20 µm. Results shown are representative of at 
least three individual experiments. 
 
The cholesterol content of the plasma membrane is important for receptor 
endocytosis. Methyl-beta-cyclodextrin (MβCD) is an agent, known to extract 
cholesterol from the plasma membrane (Rodal et. al., 1999), thereby inhibiting 
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invagination of clathrin-coated pits (Rodal et. al., 1999 ). When HEK-293 cells 
expressing the rP2Y2-GFP receptor were pretreated with 5 mM MβCD to deplete 
plasma membrane cholesterol, the rP2Y2-GFP receptor did not internalize either in 
unstimulated cells (Fig. 3.11, A1) or in cells stimulated with 100 µM UTP for 30 min 
(Fig. 3.11, A2). After a 60 min UTP stimulation in the presence of MβCD (Fig. 3.11, 
A3), however, internalized receptors were observed close to the plasma membrane (bold 
arrow) and in some cells there was a punctate appearance (broken arrow) of receptor-
containing vesicles, indicating that depletion of plasma membrane cholesterol 
significantly altered the rate and extent of P2Y2-GFP receptor endocytosis. The 
endocytosed receptor exhibits a punctate distribution indicating that the receptor is not 
targated to lysososmes. This punctate distribution of the receptor points to the fact that 
cholesterol depletion does affect the targeting of the receptor. 
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Figure 3.11: Effect of the cholesterol-extracting agent methyl-beta-cyclodextrin 
(MβCD), on rP2Y -GFP receptor endocytosis. HEK-293 cells expressing the rP2Y2 2-
GFP receptor were preincubated with 5 mM MβCD for 30 min at 37 °C (A1), then 
incubated in the presence of 100 µM UTP for 30 min (A2) and 60 min (A3), and images 
were collected. In MβCD-treated cells, receptor endocytosis is inhibited for the first 30 
min (as seen in A2) and at the end of 60 min there is a punctate distribution of the 
endocytosed receptor (arrows in A3). Scale bar is 20 µm. Results shown are 
representative of at least three individual experiments. 
 
To further confirm that endocytosis of the P2Y2-GFP receptor was independent 
of caveolin, cells were preincubated with 10 µM filipin III, an inhibitor of caveolin-
mediated pathways (Orlandi et. al., 1998), prior to stimulation with 100 µM UTP. 
Filipin III did not affect the shape nor induce receptor internalization in unstimulated 
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cells (Fig.3.12, A1), but receptors were completely internalized after a 30 min (Fig. 
3.12, A2) or 60 min UTP stimulation (Fig. 3.12, A3), consistent with the conclusion that 
internalization of the P2Y -GFP receptor is mediated by a clathrin-dependent pathway. 2
 
 
A1 A2 A3  
 
 
 
 
 
 
 
Figure 3.12: Effect of filipin-III, inhibitor of caveolin mediated endocytosis on 
rP2Y -GFP receptor endocytosis. HEK-293 cells expressing the rP2Y2 2-GFP receptor 
were preincubated with 10 µM filipin III for 30 min at 37 °C (A1), then incubated in the 
presence of 100 µM UTP for 30 min (A2) and 60 min (A3), and images were collected. 
Filipin III is an inhibitor of caveolin- mediated endocytosis. It has no effect on the 
endocytosis of the receptor, as complete endocytosis of the receptor is observed after 30 
min in filipin III-treated cells. Scale bar is 20 µm. Results shown are representative of at 
least three individual experiments. 
 
3.7 Reappearance of the P2Y2 receptor after receptor 
internalization 
_HEK-293 cells expressing the rP2Y2 GFP receptor were preincubated for 30 min 
with 100 nM LysoTracker (Fig. 3.13A) and incubated for 60 min in the presence of 100 
µM UTP to induce receptor internalization (Fig. 3.13B). It is observed that the 
internalized receptor is colocalized with lysosomes (Fig. 3.13B bold arrows). Then, the 
cells were washed and allowed to recover in agonist-free medium for 4 h 30 min prior 
to cell imaging, whereupon receptors remained internalized as aggregates outside of 
lysosomes (Fig. 3.13C, broken arrows).  
Trafficking of receptors from endosomes to lysosomes is known to occur via an 
intermediate multivesicular body complex (Miwako, et.al., 2001). To investigate the 
proteasome-dependent trafficking of rP2Y2-GFP receptors from endosomes to 
lysosomes, we preincubated the cells with 10 µM MG-132, a proteasome inhibitor 
(Haglund et. al., 2003). Pretreatment of the cells with MG-132 did not affect cell 
morphology or receptor distribution in unstimulated cells (Fig. 3.13D), whereas in cells 
 45
stimulated with 100 µM UTP for 60 min, there was complete endocytosis of the 
receptor in large aggregates outside of lysosomes (Fig. 3.13E, bold arrows). This is 
different from that seen in the absence of the inhibitor, where the endocytosed receptor 
is colocalized with lysososems (Fig.3.13B bold arrows). After a 4 h 30 min recovery 
period, P2Y2-GFP receptors had reappeared at the plasma membrane (Fig. 3.13F, 
broken arrows). The pattern observed in Fig. 3.13F is different from that exhibited in 
3.13C, as there are no vesicular structures that are present in the cytoplasm, indicating 
that MG-132 prevented trafficking of the endocytosed receptors to lysosomes and 
promoted receptor distribution in cytoplasmic vesicles that facilitated recycling of 
internalized receptors back to the plasma membrane. Thus, targeting of the P2Y2-GFP 
receptor to lysosomes probably involves a proteasome-dependent pathway. 
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Figure 3.13: Recyling of the internalized rP2Y2-GFP receptor. HEK-293 cells 
expressing the rP2Y2-GFP receptor (green) were preincubated with 100 nM 
LysoTracker (red) for 30 min at 37 °C (A), then cells were incubated for 60 min in the 
presence (B) of 100 µM UTP, and images were collected. UTP-stimulated cells also 
were washed three times and allowed to recover for 4 h 30 min in agonist-free medium, 
and images were collected (C). Other cells were pretreated with 100 nM LysoTracker 
and 10 µM MG-132 (D), then incubated in the presence of 100 µM UTP for 60 min at 
37 °C (E), allowed to recover for 4 h 30 min in the continued presence of MG-132 (F), 
and images were collected. MG-132 is a proteasome inhibitor. In cells treated with MG-
132 there is an inhibition of the targeting of the endocytosed receptor to lysosomes (as 
seen in E, indicated by bold arrow), different from B with colocalization of endocytosed 
receptor with lysosomes (bold arrow). A complete reappearance of the receptor back to 
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the plasma membrane (as seen in F, broken arrow) was observed in MG-132-treated 
cells, whereas in untreated cells there are aggregates of endocytosed receptor (C, broken 
arrow). Scale bar, 20 µm. Results shown are representative of at least three individual 
experiments. 
 
3.8 Role of kinases and phosphotases in modulating the 
translocation of the rP2Y2-GFP receptor 
Kinases play an important role in modulating the signaling mediated via 
GPCR’s. In case of the P2Y receptors the role of kinases in modulating the translocation 
of the receptor is not well studied. In the P2Y2 receptor it is know that there are a 
number of possible amino acid residues that could be phosphorylated by calcium/ 
calmodulin dependent kinase II (CaMK II) and protenin kinase –C (PKC) (Garrad et. 
al., 1998). The role of these kinases was investigated only on their ability to modulate 
the initial Ca2+ response (Garrad et. al., 1998). However the role of these kinases in 
modulating the translocation of the receptor has not been studied. Therefore we 
investigated the effect of different kinases in modulating the receptor translocation. 
 
3.8.1 Role of Calcium / Calmodulin dependent protein kinase II 
(CamK II) 
 
HEK-293 cells stably expressing the rP2Y2-GFP receptor were pre-incubated for 
30 min with 10 µM of KN-62, a specific inhibitor of CaMK-II (Davies et. al, 2001). The 
cells were stimulted with 100 µM UTP. 30 min of preincubation of the cells with 10 µM 
KN-62 did not alter the distribution of the receptor or the morphology of the cell (Fig. 
3.14A). After 30 min of stimulation with 100 µM UTP, no endocytosis of the receptor 
was observed (3.14B). After 60 min of stimulation with UTP in presence of KN-62, 
endocytosis of the receptor could be visualized (Fig. 3.14C). The endocytosis of the 
receptor that visualized was not to the same extent as observed in untreated cells. The 
cells were washed free of the agonist and were further visualized for 90 min in the 
continued presence of 10 µM KN-62. It was seen that the receptor partially reappears to 
the plasma membrane (Fig 3.14D). The effect of 10 µM KN-62 on modulating the 
initial Ca2+ response was investigated and we observed that pretreated cells exhibited a 
Ca2+ response that was 50 % of that obtained in untreated cells, when they were 
challenged with 100 µM UTP. Thus we can conclude that KN-62 modulates the initial 
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2+Ca  response and also does play an important role in modulating the trafficking of the 
receptor.  
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Figure 3.14: Role of CaMK II in modulating the trafficking of P2Y2-GFP receptor. 
HEK-293 cells expressing the P2Y2-GFP receptor were pre-treated for 30 min with 
10µM KN-62 (A) and then stimulated for 30 (B) and 60 min (C) with 100 µM UTP. 
The cells were then washed free of agonist and visualized for further 90 min (D). Pre-
incubation of the cells with KN-62 delays endocytosis of the receptor. Results shown 
are representative of at least three individual experiments. Scale bar 20 µm. 
 
3.8.2 Effect of protein phosphatases on modulating the receptor 
translocation 
De-phosphorylation of receptors too in know to play an important role in the 
recycling the GPCR’s (Oakley et. al., 1999). However, in case of the P2Y2 receptors 
this effect has till now not been investigated. We pre-incubated the cells for 30 min with 
5 nM of okadaic acid, a specific inhibitor of protein phosphatase 2A (PP2A) at this 
concentration (Schonthal 1998). The effect of the inhibitor on the Ca2+ signaling in the 
cells was investigated. The pre-incubation resulted in a reduction of the initial Ca2+ 
response which was 49% compared to that obtained with untreated cells. At the level of 
endocytosis, pre-incubation of the cells with okadaic acid did not influence the shape of 
the cells, the distribution of the receptor (Fig 3.15A) and the endocytotic kinetics of the 
receptor. A complete endocytosis of the receptor was observed after 30 min of 
stimulation of the cells with 100 µM UTP (Fig 3.15B). The agonist was withdrawn and 
the cells were allowed to recover, in the presence of the inhibitor. After 90 min of 
removal of the agonist it was observed that there was a reduced reappearance of the 
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receptor on the plasma membrane (Fig 3.15C), in comparison to cells that were not 
exposed to the inhibitor. After 120 min of withdrawal of the agonist it was observed that 
there was only a partial recovery of the receptor. These results indicate that the 
dephosphorylation of the receptor is important for the trafficking of the receptor back to 
the plasma membrane. 
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Figure 3.15: Role of Protein phosphatase 2A in modulating the trafficking of P2Y2-
GFP receptor. HEK 293 cells expressing the P2Y2-GFP receptor were pre-treated for 
30 min with 5nM okadaic acid, a specific inhibitor of protein phosphatase 2A (A) and 
then stimulated for 30 min(B) with 100 µM UTP. The cells were then washed free of 
agonist and visualized for further 60 min (C). Pre-incubation of the cells with okadaic 
acid does not affect the endocytosis of the receptor, but delays the reappearance of the 
receptor. Scale bar, 20 µm. Results shown are representative of at least three individual 
experiments. 
 
3.8.3 Role of Protein Kinase C (PKC) in trafficking of the receptor 
Protein kinsae-C comprise of a family of kinases that play an important role in 
modulating activity of different protiens like Na+ K+ ATPase (Dada et. al., 2003), actin 
cytoskeleton (Larsson 2006) and GPCR trafficking (Namkung and Sibley 2004) The 
PKCs can be divided into three categories, namely Ca2+ dependent, Ca2+ independent 
and atypical. We investigated the role of these kinases in controlling the kinetics of 
endocytosis of the P2Y2 receptor and its localization, using the commercially available 
subtype specific inhibitors for PKCs.  
2+ 3.8.3.1 Effect of Inhibition of Ca  dependent PKCs 
This subclass comprises of PKC alpha and beta. The cells were pre-treated for 1 hour 
with 1 µM GO 6976. After 60 min of pre-incubation with inhibitor, 100 nM of 
lysotracker red was added to the culture medium (Fig. 3.16A). The Ca2+ response 
observed to 100 µM UTP from pre-treated cells was 26% of that obtained from 
untreated cells. The cells were stimulated with 100 µM UTP in continual presence of 
the inhibitor. It is observed that in the first 30 min there is an inhibition of endocytosis 
of the receptor (Fig. 3.16B). Endocytosis of the receptor was observed at the end of 60 
min, but there was no colocalization of the endocytosed receptor with lysosmes (Fig 
3.16C) (bold arrows). When the cells were allowed to recover for 90 min in the absence 
of agonist, but in the continued presence of inhibitor it was observed that there is a 
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partial reappearance of the receptor on the plasma membrane (Fig. 3.16D). (bold 
arrows). In case of untreated cells a partial reappearance of the receptor (cf Fig. 3.13C) 
was observed after 4. hours 30 min of withdrawal of agonist. Thus it indicates that the 
Ca2+ dependent PKCs modulate both the endocytosis and reappearance of the P2Y2 
receptor. 
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2+Figure 3.16: Role of Ca  dependent protein kinase C (PKCs) in modulating the 
trafficking of P2Y -GFP receptor.  2
HEK-293 cells expressing the rP2Y2-GFP receptor (green) were preincubated with 1 
µM GO 6976, a specific inhibitor of Ca2+ dependent protein kinases for and 100 nM 
LysoTracker (red) at 37 °C (A). Then cells were incubated for 30 min (B) and 60 min 
(C) in the presence of 100 µM UTP, and images were collected. UTP-stimulated cells 
also were washed three times and allowed to recover for 90 min in agonist-free medium, 
and images were collected (D). Pre-treatment of the cells with GO 6976 delays 
endocytosis of the receptor and prevents colocalization of the endocytosed receptor with 
lysosomes. It hastens up the reappearance of the receptor back to the plasma membrane. 
Scale bar, 20 µm. Results shown are representative of at least three individual 
experiments. 
 
 3.8.3.2 Effect of a broad spectrum inhibitor of PKCs 
The inhibitor GF 109203X is a broad spectrum inhibitor of the members of the PKC 
family mainly consisting of both the Ca2+dependent and independent PKCs. At the 
concentration of 1 µM in inhibits PKCα,βI,βII,γ,δ,ε. The cells were pre-incubated for 1 
h with 1 µM of the inhibitor (Fig.3.17 A) and for 30 min with 100 nM lysotracker red. 
and stimulated with 100 µM of UTP for 60 min. The initial Ca2+ response obtained from 
these cells was 51% of that obtained from untreated cells. A slightly delayed 
endocytosis of the receptor is observed (Fig. 3.17 B), as 40 min is required for complete 
endocytosis of the receptor in comparison to 30 min that is observable in the absence of 
the inhibitor (Fig. 3D). This indicates that a broad spectrum inhibitor does not 
drastically affect the endocytosis kinetics of the P2Y2 receptor. After 60 min of 
stimulation with UTP there is a colocalization of the receptor with lysosomes is 
observed (Fig. 3.17C) (bold arrows). This is the second difference that is observed 
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between the trafficking of the P2Y2 receptor when the cells were pre-treated with the 
Ca2+ specific inhibitor of PKCs and the broad-spectrum inhibitor of PKCs.  
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Figure 3.17: Role of protein kinase C (PKCs) in modulating the trafficking of 
P2Y -GFP receptor. HEK-293 cells expressing the rP2Y2 2-GFP receptor (green) were 
preincubated with 1 µM GF 109203 X, a broad spectrum inhibitor of protein kinases for 
60 min and 100 nM LysoTracker (red) 37 °C (A). Then cells were incubated for 60 min 
in the presence (C) of 100 µM UTP, and images were collected. Pre-treatment of the 
cells with GF109203 X resulted in delayed endocytosis of the receptor (B) 40 min is 
required for the complete endocytosis of the receptor in comparision to 30 min in 
untreated cells .It does not prevent colocalization of the endocytosed receptor with 
lysosomes. Scale bar, 20 µm. Results shown are representative of at least three 
individual experiments. 
 
 3.8.3.3Effect of inhibition of atypical PKCs 
This family of PKCs includes PKC ζand δ. At 1µM GO 6983 specifically inhibits only 
the atypical PKCs (Javed et. al., 2004). The protocol for the internalization experiments 
was identical to that used for the other inhibitors of the PKC family. In case of 
experiments with GO6983 the META channel and the technique of online emission 
fingerprinting was used for detection of the emitted fluorescence as the inhibitor is 
excitable at 543 nm, and emits at 620nm. The technique of online finger printing 
employs the principle of linear unmixing. In this method the emission spectrum of each 
of the putative fluorophore is initially recorded in exactly the same experimental 
configuration for which the technique would be applied. During the course of the 
experiment the pre-recorded spectra are used to calculate the exact percentual 
contribution of each of the flurophore in a give pixel (Dickinson et. al., 2001). Pre-
incubation of the cells with the inhibitor did not affect the shape of the cells or the 
loading with lysotracker Red (Fig. 3.18A). However pre-treatment of the cells with 
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inhibitor did decrease the initial Ca2+ response by 47 % in comparison to that exhibited 
by untreated cells. Normal endocytosis of the receptor was observed after 30 min of 
stimulation with 100µM UTP (Fig.3.18B). It was interesting to observe that after 40 
min of treatment with UTP a colocalization of the endocytosed receptor was observed 
with lysososmes (Fig.3.18C) (bold arrows). This is different from that observed in case 
of untreated cells, where colocalization was observed after 60 min of stimulation with 
UTP (cf. Fig. 3.13B). This indicates that the inhibiton of the atypical PKCs accelerates 
the translocation of the endocytosed receptor to lysososmes. When the cells were pre-
incubated with 5 µM GO 6983, a colocalization between the endocytosed receptor and 
the lysosomes is observed 30 min after stimulation of the cells with 100 µM UTP. 
When the cells were allowed to recover for 90 min in the presence of 1 µM GO 6983 a 
weak reappearance of the receptor on the plasma membrane is observed and most of the 
endocytosed receptor is redistributed in the cytoplasm is large aggregates (Fig 3.18D) 
(bold arrows). There is no localization of the receptor with lysosomes. This is similar to 
the results obtained when normal endocytosis of the receptor is observed. This could 
lead us to speculate that the endocytosis of the receptor is modified, but the 
reappearance of the receptor is not drastically affected. 
 A B 
C D 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.18: Role of atypical PKCs in modulating the trafficking of the P2Y2-GFP 
receptor. HEK-293 cells expressing the rP2Y2-GFP receptor (green) were preincubated 
with 1 µM GO 6983, a specific inhibitor of atypical protein kinases for 60 min and 100 
nM LysoTracker (red) for 30 min and at 37 °C (A). Then cells were incubated for 30 
min (B) and 40 min in the presence (C) of 100 µM UTP, and images were collected. 
UTP-stimulated cells also were washed three times and allowed to recover for 90 min in 
agonist-free medium, and images were collected (D). Pre-treatment of the cells with GO 
6983 does not affect the rate of endocytosis of the receptor but hastens the 
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colocalization of the endocytosed receptor with lysosomes. There is a weak 
reappearance of the receptor back to the plasma membrane. Scale bar, 20 µm. Results 
shown are representative of at least three individual experiments. 
 
3.8.4 Role of phosphoinositol-3-kinase (PI3K) in P2Y2 receptor 
trafficking 
The cells were simultaneously preincubated with 100 nM lysotracker Red and 
wortmannin, to label lysosmes and a specific inhibitor of PI3K, respectively (Fig. 
3.19A). The initial Ca2+ signal that was observed on challenging the pre-treated cells 
with 100 µM UTP was 31% of that observed in untreated cells. After 30 min of 
stimulation with 100 µM UTP it is observed that there is complete endocytosis of the 
receptor (Fig. 3.19B), but there no colocalization of the endocytosed receptor with 
lysosomes. This is similar to that is observed in case of untreated cells. After further 30 
min of stimulation it is seen that there is a aggregation of the receptor in form of large 
vesicles, but it is not colocalized with the lysosomes (Fig. 3.19C). This indicated that 
the pre-incubation of the cells with wortmannin did not affect the temporal kinetics of 
endocytosis of the receptor, but its targeting to lysosomes. Though a colocalization of 
the receptor with the lysosomes seems apparent from the figure (Fig. 3.19B), it is clear 
from the X-Z and Y-Z projections that the lysosomes and the endocytosed receptor 
vesicles are present in different cellular levels. After 360 min of removal of agonist, it is 
observed that the receptor did not reappear on the plasma membrane and is still present 
in large aggregates in the cytosol and it is not localized with the lysosomes (Fig. 3.19D). 
This is an additional difference that is observed to untreated cells, where a partial 
reappearance of the receptor is observed on the plasma membrane (ref. Fig. 3.13C). 
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Figure 3.19: Role of PI3 kinase in modulating the trafficking of the P2Y2 receptor. 
HEK-293 cells expressing the rP2Y2-GFP receptor (green) were preincubated with 100 
nM wortmannin, a specific inhibitor of PI3 kinases for 60 min and 100 nM LysoTracker 
(red) for 30 min at 37 °C (A). Then cells were incubated for 30 min (B) and 60 min in 
the presence (C) of 100 µM UTP, and images were collected. UTP-stimulated cells also 
were washed three times and allowed to recover for 360 min in agonist-free medium, 
and images were collected (D). Pre-treatment of the cells with wortmannin does not 
affect the rate of endocytosis of the receptor but prevents the colocalization of the 
endocytosed receptor with lysosomes. There is a weak reappearance of the receptor 
back to the plasma membrane. Scale bar, 20 µm. Results shown are representative of at 
least three individual experiments. 
 
3.8.5 Modulation of P2Y2 receptor endocytosis by Rho-A kinase 
Rho kinase has been know to be involved in modulating the activity of GPCRs 
as the kinases in this family are actively involved in the remodeling of the actin 
cytoskeleton, which is one of the factors involved in endocytosis of the GPCRs 
(Mueller and Strange, 2004). We pre-incubated the cells with 10 µM of Y-27632, a 
specific inhibitor of RhoA kinase (Smith et. al., 2001). The pre-incubation of the cells 
with the inhibitor did not affect the loading of the lysotracker red and the localization of 
the receptor (Fig. 3.20A). After 30 min of stimulation of the cells with 100 µM UTP 
there was a minimal endocytosis of the receptor (Fig. 3.20B). This is similar to that 
which is observed in case of cells pre-incubated with 100 nM Cytochalasin-D (ref- 
Fig.3.6.A2), an inhibitor of actin cytoskeleton. However, preincubation of the cells with 
the inhibitor reduce the initial Ca2+ response exhibited by the cells to 100 µM UTP by 
14% compared to untreated cells. This indicates that though the pre-treatment of the 
cells with Y-27632 affected the endocytotic kinetics of the receptor but not significantly 
the initial calcium response. After further continual stimulation with 100 µM UTP, 
endocytosis of the receptor was observed, but there was no colocalization of the 
endocytosed receptor with lysosomes (bold arrows) (Fig. 3.20C). The endocytosed 
receptor did not form the large aggregate that is observed in untreated cells. After 
withdrawal of the agonist it is observed that there is a partial reappearance of the 
receptor on the plasma membrane (Fig. 3.20D). This indicates that the inhibition of the 
RhoA kinase plays an important role in the trafficking of the receptor. This corroborates 
our data that is obtained with cytochalasin-D and ML-9, that in addition to actin, the 
supporting machinery that is involved in aiding the remodelling of the actin 
cytoskeleton has to be intact to promote normal trafficking of the receptor. 
Figure 3.20: Role of RhoA kinase in modulating the trafficking of the rP2Y2-GFP 
receptor. HEK-293 cells expressing the rP2Y2-GFP receptor (green) were preincubated 
with 10 µM Y-27632, a specific inhibitor of RhoA kinases for 60 min and 100 nM 
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LysoTracker (red) for 30 min and at 37 °C (A). Then cells were incubated for 30 min 
(B) and 60 min (C) in the presence of 100 µM UTP, and images were collected. UTP-
stimulated cells were then washed three times and allowed to recover for 90 min in 
agonist-free medium, and images were collected (D). Pre-treatment of the cells with Y-
27632 caused a minimal internalization of the receptor after 30 min of stimulation and 
prevented co-localization of the internalize receptor with lysosomes at the end of 60 
min. There is a partial reappearance of the receptor back to the plasma membrane. Scale 
bar, 20 µm. Results shown are representative of at least three individual experiments. 
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3.8.6 Role of Mitogen Activated Protein Kinase (MAPK) in modulating 
endocytosis of the P2Y2 receptor 
MAP kinases (MAPK) have been shown to be activated on stimualtion of a 
number of GPCRs (Schmidt et. al.,2000; Wang et. al, 2002), but their role in 
modulating the endocytosis of the P2Y receptor endocytois has not been well studied. 
The MAPK cascade comprises a number of kinases which are phosphorylated in a 
sequential manner finally resulting in the phosphorylation of MAPK. The activated 
MAPK can then result in stimulation of proliferation (Wang et. al., 2003). We wanted to 
investigate the role of the activated MAPK in modulating the trafficking of the P2Y2 
receptor. To study this, we inhibited the activation of the MAPK by inhibiting the 
activity of MAPK kinase (MEK) with 10 µM U0126. After 30 min of pre-incubation 
(Fig. 3.21A), the cells were treated for 60 min with 100 µM UTP. It is seen that after 30 
min of stimulation, internalization of the receptor is observed (Fig. 3.21B), but the 
internalized receptor is present in small vesicles (indicated by arrows) distributed in the 
cytoplasm. This is different from the pattern that is observed in untreated cells (ref. Fig. 
2A1). After further 30 min of stimulation an aggregation of the endocytosed receptor is 
observed (Fig. 3.21C). This indicates a similar pattern of aggregation of the receptor as 
in untreated cells. After 90 min of withdrawal of agonist there is a partial reappearance 
of the receptor on the plasma membrane (Fig. 3.21D). Thus we can infer that although 
the initial endocytosic pattern of the receptor was different from that in case of 
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untreated cells, the reappearance pattern of the receptor seems to be similar to that 
observed in untreated cells. 
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Figure 3.21: Role of MEK in modulation of P2Y2 receptor trafficking. HEK-293 
cells expressing the rP2Y2-GFP receptor were preincubated with 10 µM U-0126, a 
specific inhibitor of MAPK kinases for 60 min and at 37 °C (A). Then cells were 
incubated for 30 min (B) and 60 min (C) in the presence of 100 µM UTP, and images 
were collected. UTP-stimulated cells also were washed three times and allowed to 
recover for 90 min in agonist-free medium, and images were collected (D). Pre-
treatment of the cells with U 0126 does not affect the rate of endocytosis of the receptor. 
There is a weak reappearance of the receptor back to the plasma membrane. Scale bar, 
20 µm. Results shown are representative of at least three individual experiments. 
 
3.9 Effect of Phospholipase D2 (PLD2) on endocytosis of the 
P2Y2 receptor 
Phospholipases have been implicated in modulation of the endocytosis of 
receptors (Du et. al., 2004; Shen et. al., 2001). To determine the role ofPLD2 in 
endocytosis of the P2Y2 receptor the cells were treated either with 1-butanol or 2-
butanol. 1-butanol is used to check if PLD2 has a role in a given process because of the 
virtue of the transphosphatidylation reaction, whereby the enzyme preferentially utilizes 
a primary alcohol over water to generate a phosphatidylalcohol instead of phosphatidic 
acid. Thus, the presence of a primary alcohol inhibits the production of phosphatidic 
acid by PLD. The reaction is highly specific for primary alcohols and secondary 
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alcohols are not utilized by PLD. Thus 2-butanol is used as a negative control (Morris 
et. al., 1997). The cells were pre-incubated with 0.75% 1-butanol (Fig 3.22A) for 30 
min and then stimulated with 100 µM UTP. It is observed that for the first 30 min there 
is no endocytosis of the receptor (Fig. 3.22B). After 60 min of stimulation there is only 
a partial endocytosis of the receptor observed (Fig 3.22C). This indicates that inhibition 
of PLD  inhibits the endocytosis of the P2Y2 2 receptor. After 30 min of withdrawal of 
the agonist, in the continual presence of the inhibitor, endocytosis of the receptor was 
observed (Fig 3.22D). The percentage of endocytosis further increased 60 min after 
withdrawal of the agonist (Fig 3.22E).This means that inhibition of the PLD2 pathway 
does delay the endocytosis of the receptor but still the kinases could be still active the 
trafficking pattern still seems similar to that seem in the case of protein kinase-C 
mediated. 
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Figure 3.22: Role of PLD  in modulation of P2Y2 2 receptor trafficking. HEK-293 
cells expressing the rP2Y2-GFP receptor were preincubated with 0.75% v/v 1-butanol, a 
specific inhibitor of PLD2 for 60 min and at 37 °C (A). Then cells were incubated for 30 
min (B) and 60 min (C) in the presence of 100 µM UTP, and images were collected. 
UTP-stimulated cells were washed three times and allowed to recover for 30 min (D) 
and 90 min (E) in agonist-free medium, and images were collected. Pre-treatment of the 
cells with 1-butanol delays the rate of endocytosis of the receptor. There is a weak 
reappearance of the receptor back to the plasma membrane after withdrawal of agonist. 
Scale bar, 20 µm. Results shown are representative of at least three individual 
experiments. 
 
To confirm the role of PLD  in modulating the translocation of the P2Y2 2 
receptor, the cells were preincubated for 30 min with 0.75% v/v 2-butanol (Fig. 3.23 A). 
2-butanol is an inactive analogue of 1-butnol, as it does not inhibit the function of PLD . 2
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It was seen on stimulation of the 2-butanol pre-treated cells with 100 µM UTP, 
complete endocytosis of the receptor is observed after 30 min (Fig.3.23B) and a 
translocation of the endocytosed receptor to the lysosomes (Fig 3.23C) (bold arrows) is 
seen after 60 min of stimulation with UTP. The endocytotic kinetic is similar to that 
exhibited by untreated cells. Thus we can infer that PLD2 is involved in modulating the 
trafficking of the P2Y  receptor. 2
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Figure 3.23: Effect of 2-butanol in modulating the endocytosis of the P2Y2 
receptor. HEK-293 cells expressing the rP2Y2-GFP receptor (green) were preincubated 
with 0.75% (v/v) 2-butanol for 60 min and 100 nM LysoTracker (red) for 30 min at 
37°C (A). Then cells were incubated for 30 min (B) and 60 min (C) in the presence of 
100 µM UTP, and images were collected. Pre-treatment of the cells with 2-butanol does 
not affect the rate of endocytosis of the receptor and the colocalization of the 
endocytosed receptor with lysosomes. This indicates that 2-butanol does not affect the 
endocytosis of the receptor. Scale bar, 20 µm. Results shown are representative of at 
least three individual experiments. 
 
 
3.10 Effect of ATP on UTP on differential trafficking of the 
P2Y2-GFP receptor 
The cells were stimulated with 100 µM ATP or UTP for 30 min or 60 min. The cells 
were then washed and allowed to recover for 60 min. It is observed that there is a 
difference observed in the trafficking of the receptor depending on the duration of 
stimulation with the different agonists. In case of a 30-min stimulation with either 100 
µM ATP (Fig. 3.24B) or UTP (Fig. 3.24C), a complete endocytosis of the receptor was 
observed. After the withdrawal of the agonist and after an hour’s recovery it is observed 
that in both cases there is complete reappearance of the receptor on the plasma 
membrane (Fig. 3.24D and E). This indicates that when cells were stimulated for 30 min 
with 100 µM ATP or UTP, there was no observable difference in the pattern of 
endocytosis or reappearance of the receptor, corroborating the fact that ATP and UTP 
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function as equipotent agonists at the P2Y2 receptor. So we stimulated the cells for 60 
min with 100 µM of either ATP (Fig. 3.24F) or UTP (Fig. 3.24G) and allowed the cells 
to recover for 1 h. An interesting difference is observed in the trafficking of the 
receptor, although both agonists are equipotent on the P2Y2 receptor. A 60 min 
stimulation with 100 µM UTP and ATP resulted in a complete endocytosis of the 
receptor. In case of ATP-stimulated cells there is a significant reappearance of the 
receptor on the plasma membrane after 1 h of withdrawal of the agonist, (Fig. 3.24H) 
whereas in UTP-treated cells there is a minimal reappearance of the receptor on the 
plasma membrane (Fig. 3.24I). This indicates that the stimulation of the cells with 100 
µM UTP or ATP for 60 min leads to a different trafficking of the endocytosed receptor, 
which then leads to the different degrees of reappearance of the receptor back to the 
plasma membrane.  
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Figure 3.24: Differential trafficking of the P2Y2-GFP receptor on stimulation with 
ATP and UTP. HEK-293 cells expressing the rP2Y2-GFP receptor (A) were stimulated 
with 100 µM ATP (B) or UTP (C) for 30 or 60 min, respectively at 37 °C. Then the 
cells were allowed to recover for 60 min and then fixed (as described in Materials and 
Methods). In case of unstimulated cells (A) the receptor is localized on the plasma 
membrane and on stimulation for 30 min with 100 µM ATP (B) or UTP (C) a complete 
endocytosis of it is observed. A complete reappearance of the receptor at the plasma 
membrane is observed after 60 min of withdrawal of ATP (D) and UTP (E). Similarly 
60 min stimulation of the cells with 100 µM ATP (F) or UTP (G) results in complete 
endocytosis of the receptor. A 1 h. withdrawal of the agonist results in significant 
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reappearance of the receptor in case of ATP (H) and not UTP (I). Scale bar, 20 µm. 
Results shown are representative of at least three individual experiments. 
 
This is an interesting difference that we observed in comparison to the P2Y1 
receptor. When HEK 293 cells stably expressing the P2Y1-GFP receptor (Fig. 3.25A) 
were subjected to the above protocol, we observed that either in case of a 30 min (Fig. 
3.25) or of 60 min (Fig. 3.25C) stimulation of the cells with 100 µM ATP the P2Y1 
receptor did completely recycle back to the plasma membrane one hour after 
withdrawal of the agonist (Fig. 3.25D and E). This indicates that in the same cell, 
stimulation of the cell with ATP results in different trafficking pathway of two types of 
receptors. 
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Figure 3.25: Trafficking of the P2Y1-GFP receptor upon stimulation with ATP. 
HEK-293 cells expressing the rP2Y1-GFP (A) receptor were stimulated with 100 µM 
ATP for 30 min (B) or 60 min (C) at 37 °C. Then the cells were allowed to recover for 
60 min and then fixed (as described in Material and Methods). In case of unstimulated 
cells (A) the receptor is localized on the plasma membrane and stimulation with 100 
µM ATP for 30 min (B) or 60 min (C) results in a complete endocytosis of the receptor. 
Irrespective of the initial duration of stimulation, a complete reappearance of the 
receptor at the plasma membrane is observed after 60 min of withdrawal of ATP (D and 
E). This indicates that the receptor reappeared on the plasma membrane after either 30 
min (D) or 60 min of stimulation (E). Scale bar, 20 µm. Results shown are 
representative of at least three individual experiments. 
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3.11. Interaction of Diadenosine polyphosphates with P2Y2 
receptor 
Diadenosine polyphosphates are an important class of molecules that play an 
important role physiological role both intracellularly and extracellularly in modulating 
cellular function. The current hypothesis is that the diadenosine polyphosphates exert 
their physiological actions via the P2 receptors or via a separate class of GPCRs. The 
theory for the presence of a separate class of receptors that are activated by the 
diadenosine polyphosphates is further supported by the fact that a residual cellular 
response to nucleotides is observed in cells that were pre-treated with P2 receptor 
antagonist. So we decided to investigate the role of diadenosine polyphosphates in 
signaling via the P2Y2 receptor using HEK 293 cells stably transfected with the P2Y2-
GFP receptor. We investigated the role of these substances in their ability to stimulate 
an increase in intracellular calcium and possibly induce endocytosis of the receptor. We 
also investigated their role in modulating the targeting of the endocytosed receptor and 
receptor mediated cell proliferation as parameters to study the role of modulation of 
P2Y  receptor function by diadenosine polyphosphates. 2
 3.11.1 Effect of diadenosine polyphosphates in stimulating a rise 
in [Ca2+]i
Changes in intracellular calcium were measured using the protocol that was used for 
confirming the functional expression of the P2Y2-GFP receptor. The role of different 
diadenosine polyphosphates, namely Ap2,3,4,5A, were investigated in their ability to 
influence the intracellular calcium levels.  
 1.6
C
a
 r
is
e 
(f
lu
or
es
ce
nc
e 
ra
tio
 
 3
40
 n
m
 / 
38
0n
m
) 
 1.4 AP2A
AP3A 1.2
AP4A 
AP5A
 
 
 
 
 
 
 
log concentration of agonist 
0
0.2
0.4
0.6
-10 -9 -8 -7 -6 -5 -4 -3
UTP
1.0 
0.8
2+
 61
Figure 3.26: Concentration–response curves for Ca2+ rise induced by diadenosine 
polyphosphates (Ap As) in HEK 293 cells expressing the P2Y -GFP receptor.  n 2
HEK 293 cells stably expressing the rP2Y2-GFP receptor were preloaded with Fura-
2/AM and then superfused with NaHBSS containing Ca2+ and stimulated for 1 min with 
the different concentrations of agonists. The concentration-dependent rise in Ca2+ is 
measured as the ratio between the fluorescence obtained at 340 nm and 380 nm upon 
stimulation with different concentrations of Ap A (closed circles), Ap2 3A (open squares), 
Ap A (closed triangles), Ap4 5A (open triangles) and UTP (closed diamonds). The data 
are from Ca2+ recordings in single cells and represent the mean ± s.d. from at least 50 
cells for each value. 
 
The dose response curve for the Ca2+ responses that was obtained on stimulating 
the HEK 293 cells stably expressing the P2Y2-GFP receptor with different 
concentrations of diadenosine polyphosphates is shown in Fig. 3.26. We can observe 
from the dose response curve that the diadenosine polyphosphates exhibit different 
potencies in elevating the [Ca2+]i. The order of potencies that we observe from the dose 
response curves is UTP >Ap A>Ap A≥Ap A>Ap4 3 5 2A. This indicates that in the family of 
diadenosine polyphosphates Ap A is the most potent in activating the P2Y4 2 receptor. 
Since we observed this graded potency among the diadenosines in elevating the 
intracellular calcium we decided to investigate their ability to induce endocytosis of the 
P2Y2 receptor and to compare the trafficking of endocytosed receptor after stimulating 
the cells with UTP. 
3.11.2 Endocytosis and trafficking of the P2Y2 receptor by diadenosine 
polyphosphates 
The endocytosis experiments were carried on cells, that were maintained in complete 
growth medium at 370C in a humidified atmosphere of 5% CO2. The cells were 
stimulated with 100 µM diadenosine polyphosphates for 30 min and the endocytosis of 
the receptor was observed. We quantified the percentage of endocytosis of the receptor. 
We observed that after 30 min of exposure to 100 µM diadenosine polyphosphates 
endocytosis of the receptor is observed. There was a minimal endocytosis of the 
receptor in case of cells stimulated with 100 µM Ap2A for 30min (Fig.3.27 A). In case 
of cells exposed to 100 µM Ap3,4,5A endocytosis of the receptor was observed to 
different extents (Fig. 3.27 B,C and D).  
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Figure 3.27: Visualization of P2Y2-GFP receptor endocytosis induced by 
diadenosine polyphosphates. HEK 293 cells stably expressing P2Y2-GFP receptor 
were stimulated with 100 µM of agonist and were visualized on stage for 30 min at 
370C (A–D). The localization of the receptor was observed after 30 min of stimulation 
of HEK 293 cells expressing P2Y2-GFP receptor that were stimulated with 100 µM of 
(A) Ap A, (B) Ap A, (C) Ap A and (D) Ap A. 2 3 4 5
 
We quantified the percentage of endocytosed receptor (Fig. 3.28) by measuring 
the loss of fluorescence intensity on the plasma membrane. The values of endocytosis, 
that were obtained were compared to the percentage of endocytosis of the receptor 
induced by 100 µM UTP. The most selective and potent agonist of the P2Y2 receptor 
was UTP and among the diadenosine polyphosphastes the order of potency was Ap4A > 
Ap A>Ap A>>Ap5 3 2A. It is observed that the order of potency exhibited by the 
diadenosine polyphosphates is different for the order of potency exhibited in terms of 
the Ca2+ response. The difference in potency that is send between Ap5A and Ap3A at 
the level of endocytosis is not statistically significant and so it ca be considered that the 
diadenosie polyphosphates pretty much exhibit a similar order of potency both at the 
level of Ca2+ signaling and promoting endocytosis of the receptor. 
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Figure 3.28: Quantification of fluorescence intensity in HEK 293 cells stably 
expressing rP2Y2-GFP receptor. HEK 293 cells stably expressing P2Y2-GFP receptor 
were stimulated with agonist for 30 min at 370C. The translocation of the receptor was 
observed using CLSM, and the change in the fluorescence quantitated in user-defined 
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regions of interest (ROI) that encompass the cytoplasmic regions of the same cell, using 
Zeiss software. The increase of fluorescence intensities in the cytosol were used as a 
measure of the endocytosis of the P2Y2-GFP receptor. The changes in the fluorescence 
intensity after stimulation of the cells with 100 µM of UTP (open squares), Ap2A 
(closed triangles), Ap A (open circles), Ap3 4A (closed squares) and Ap5A (closed 
circles). The data represent the mean ± s.d. from at least 30 cells.  
 
We further investigated if the endocytosed receptor would co-localize with the 
lysosomes at the end of 60 min. as observed in the case of cells that were treated with 
100 µM UTP. Cells pre-loaded with 100 nM lysotracker (Fig. 3.29A) were stimulated 
with 100 µM of the different diadenosine nucleotides and observed under conditions as 
described above. It was observed that in case of Ap4A, 60 min after stimulation there 
was complete endocytosis of the receptor (Fig.3.29B) but after 80 min of continual 
presence of agonist the endocytosed receptor was colocalized with lysosomes (Fig. 
3.29C) (bold arrows).  
 
 
A B C  
 
 
 
 
 
 
 
Figure 3.29: Modulation of endocytosis of P2Y2-GFP receptor by diadenosine 
tetraphosphate. HEK-293 cells expressing the rP2Y2-GFP receptor (green) were 
preincubated with 100 nM LysoTracker (red) for 30 min at 37 °C (A), then cells were 
incubated with 100 µM Ap4A, and images were collected. It is observed after 60 min of 
stimulation (B) complete endocytosis of the receptor was observed but no colocalization 
of the endocytosed receptor with lysosomes. Further presence of Ap4A resulted in 
colocalization of the endocytosed receptor with lysosomes (bold arrows) after 80 min 
(C).  
 
The data regarding the duration required for the endocytosed receptor to be 
transported to the lysosomes on stimulation with the other diadenosine polyphosphates 
is indicated in Table 3.1. 
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Table 3.1: Localization of the endocytosed P2Y2-GFP receptor on stimulation with 100 
µM of diadenosine polyphosphate. HEK 293 stably expressing the P2Y2-GFP receptor 
were preincubated with lysotracker and stimulated with 100 µM of diadenosine 
polyphosphates until a localization of the endocytosed receptor was observed with the 
lysosomes. The data indicated here are from a minimum of 4 experiments. 
 
S.No 100 µM 
agonist 
Time for colocalization of 
endocytosed P2Y2 receptor with 
lysosomes 
1 UTP 60 min 
2 Ap A 120 min 3
3 Ap A 80 min 4
4 Ap A 100 min 5
 
Thus from the above data we can infer that though the diadaenosine 
polyphosphates do induce endocytosis of the P2Y2 receptor, they stimulate different 
pathways that differently traffic the receptor in comparison to UTP. This could be one 
of the mechanisms in addition to the different Ca2+ response that is observed on 
exposing the cells to the diadenosine polyphosphates. This could serve as a cue to the 
cell to respond specifically in a modified manner to diadenosine polyphosphates in 
comparison to nucleotide triphosphates. 
 
3.12 Role of nucleotides and diadenosine polyphosphates in 
modulation of proliferation of HEK 293 cells 
 HEK 293 cells stably expressing the rP2Y2-GFP receptor were stimulated with 
different concentrations of UTP, ATP and Ap4A for 16 h. The effect of the agonist on 
modulation of proliferation was monitored by detecting the changes in the amount of 
BrdU, that was incorporated into the cells. BrdU incorporation in the cells was detected 
using the ELISA kit from Roche (as described in Material and Methods). It is observed 
that in the case of stimulation with different concentrations of UTP, ATP and Ap4A, 
there is a dose dependent increase in the BrdU incorporation (Fig. 3.30). ATP and UTP 
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are equipotent in terms of stimulation of proliferation in the stably transfected HEK 293 
cells 
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Figure 3.30: Modulation of proliferation of HEK 293 cells stably expressing rP2Y2-
GFP receptor with different agonist. 10–100 µM ATP or UTP or Ap4A was added to 
proliferating HEK 293 cells, and bromodeoxyuridine (BrdU) incorporation was 
measured after 16 h. Values are means ± SD of 4–6 experiments run in triplicate. The 
statistical significance levels between the stimulated and control cells are * P <0.5, ** P 
< 0.001 and between UTP and Ap A is *** P <0.005 4
 
A 4-fold increase in the BrdU incorporation was observed in the Ap4A 
stimulated HEK 293 cells stably expressing the rP2Y2-GFP receptor. The effect of other 
diadenosine polyphosphates in modulating proliferation on these cells was also 
investigated using the BrdU incorporation method and the order of potency that we 
obtained was Ap A>Ap A≥Ap A>>Ap4 5 3 2A. It is known from literature that diadaenosine 
polyphosphates do undergo hydrolysis to produce ATP or ADP (Vollmayer et. al.,2003) 
Thus to confirm that the increase in the BrdU was primarily due to activation of the 
cells by diadenosine polyphosphates or due to subsequent hydrolysis to ATP or ADP we 
preincubated the cells for 1 hr with 100 µM α,β-MeADP, a potent inhibitor of 
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ectonucleotidases before stimulation of the cells with diadenosine polyphosphates in the 
continued presence of the inhibitor. The results are summarized in Table 3.2. 
S.No. Agonist Stimulation of 
proliferation (X-times 
above control) 
(mean ±S.D.) 
1 1.19 ± 0.014 100 µM α,β-Me-ADP
2 100 µM Ap A 4.03 ± 0.032 3
3 3.88 ± 0.046 100 µM α,β-Me-ADP 
+ 100 µM Ap A 3
4 100 µM Ap4A 4.82 ± 0.051 
5 4.54 ± 0.023 100 µM α,β-Me-ADP 
+ 100 µM Ap A 4
6 100 µM Ap A 3.17 ± 0.041 5
7 4.64 ± 0.064 100 µM α,β-Me-ADP 
+ 100 µM Ap A 5
 
Table 3.2: Effect of diadenosine polyphosphates on BrdU incorporation in the presence 
of α,β-Me-ADP. HEK 293 cells stably expressing the P2Y2-GFP receptor were pre-
incubated for 1 h with 100 µM of α,β-Me-ADP and then stimulated with 100 µM of 
different diadenosine polyphosphates, and the bromodeoxyuridine (BrdU) incorporation 
was measured after 16 h. Values are mean ± SD n= 4–6 experiments run in triplicate. 
 
Thus we observe that even in the presence of α,β Me-ADP the diadenosine 
polyphosphates did result in a higher BrdU incorporation than that observed when the 
cells were either stimulated with ATP or UTP. This indicates that the diadenosine 
polyphosphates do stimulate proliferation in HEK 293 cells via a signalling pathway 
that is different from that adopted by ATP or UTP. Thus taking into account the above 
sets of parameters namely modulation of intracellular Ca2+ levels, promoting 
endocytosis of the P2Y2 receptor, differential trafficking of the endocytosed receptor 
and finally their effect on modulating proliferation in HEK 293 celss we can infer that 
the diadenosine polyphosphates do signal to a large extent via the purinergic receptors. 
The signalling that is exhibited by them is however different form the classical agonist 
of the P2Y  receptor namely UTP and ATP.  2
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4. DISCUSSION: 
P2Y receptors constitute an important family of metabotropic receptors through 
which extracellular nucleotides exert their effects. The role of extracellular nucleotides 
as signaling molecules was realized in 1929, from the work of Drury and Szent-Györgyi 
who published the first report of an extracellular action of adenine compounds. It was, 
however, not until the early 1970s that their role as extracellular messengers was 
demonstrated (Burnstock et. al., 1972). Finally, in 1993 the first P2Y receptors were 
cloned (Lustig et. al., 1993; Webb et. al., 1993). Currently the P2Y receptor family 
consists of 8 functionally characterized receptor subtypes namely P2Y1,2,4,6,11,12,13,14 
(Abbracchio et al., 2003) that are expressed in humans. The P2Y2 receptor is a unique 
member of this receptor family as it responds equipotently to both UTP and ATP 
(Abbracchio et al., 2003). The P2Y2 receptor has been the protein of therapeutic interest 
in this family as it has been implicated to play a role in modulation of transport of Cl- 
ions and thus thought to be a potential target in treatment of cystic fibrosis. The 
modified agonists of the P2Y2 receptor diquafosol (diuridine tetraphosphate) and 
denufosol (uracil-cytosine dinucleotide) are currently undergoing clinical trials for is 
use in treating dry eye disease (Brunschweiger & Müller, 2006). Thus, it is important to 
understand the mechanisms that regulate the trafficking of the P2Y2 receptor. It is also 
crucial for understanding the proteins that modulate the trafficking of this receptor and 
the possible downstream proteins that are activated during the trafficking of the 
receptor.  
 
4.1 Functional Expression of the tagged rP2Y2 receptor in 
HEK 293 cells 
In the HEK 293 cell system we were able to demonstrate a functional integration 
and correct localization of the rP2Y2 receptor tagged with either a GFP or a myc-his tag 
at the C-terminus (as seen for example in Fig. 3.1). This can be concluded from the 
following experimental results. Since the expression pattern of the tagged rP2Y2 was 
similar to that of the endogenously expressed hP2Y2 receptor, we verified the functional 
expression of the receptor by measuring the calcium response obtained in the stably 
expressing cell on treating them with different concentrations of either ATP or UTP. 
We observed that there was an increase in sensitivity of the transfected cells to both 
ATP and UTP. The transfected cells exhibited an equipotent Ca2+ response to both ATP 
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and UTP independent of the tag attached to the P2Y2 receptor  (as demonstrated in Fig. 
3.2A and B). This confirmed that there is functional expression of the P2Y2 receptor in 
the HEK 293 cells. We used the HEK 293 cells as an heterologous expression system as 
it has been demonstrated that the HEK 293 cells do endogenously express the P2Y2 
receptor (Schäfer et. al., 2002). The presence of the normal signaling machinery that is 
required for the P2Y2 receptor in HEK 293 cells due to the endogenous expression of 
the hP2Y2 receptor make HEK 293 cells an ideal heterologous system for studying the 
trafficking of the P2Y2 receptor. Thus, from the above two results we can infer that we 
have functional expression of the rP2Y  with either the GFP tag or the myc-his tag.  2
We had used this system successfully to study the internalization of the rP2Y2-
GFP receptor by novel adenosine 5‘-O-(1-boranotriphosphate) derivatives (Tulapurkar 
et al., 2004), where we found that the rank order of potency of these substances in 
eliciting an increase in [Ca2+]i was also apparent for the endocytosis induced by these 
substances. We therefore proceeded to study the trafficking of the rP2Y2 receptor in this 
functional system. Stimulation of the cells expressing rP2Y2-GFP receptor with 100 µM 
UTP, which is an agonist only for the P2Y2 receptor induced internalization of the 
receptor (as seen in Fig. 3.3D). A similar internalization of the receptor was also 
observed in case of the myc-his tagged receptor. This indicates that the presence of 
either of the tags did not affect the endocytotic kinetics of the receptor. Thus, in all 
following studies we performed endocytosis experiments with the GFP tagged P2Y2 
receptor so as to aid in live cell visualization and observe the translocation kinetics of 
the receptor in the given cell population.  
 
4.2 Endocytosis pathways of P2Y2 receptor and involved 
proteins 
One of the molecular players in receptor endocytosis is actin, which is part of the 
cytoskeleton that undergoes a massive reorganization to enhance endocytosis (Lamaze 
et. al., 1997). The role of the actin cytoskeleton and clathrin in modulating the 
endocytosis of GPCRs and specifically P2Y receptors has been described (Ferguson, 
2001, Baurand et. al., 2005; Tulapurkar et. al, 2005). Clathrin-mediated endocytosis of 
many GPCRs is coupled to β-arrestin and GRKs (Reiter & Lefkowitz, 2006). We did 
not see actin stress fibers in unstimulated HEK-293 cells expressing the rP2Y2-GFP 
receptor (Fig 3.6A2) , which is consistent with a normal distribution of the actin 
cytoskeleton in unstimulated HEK-293 cells (Giancotti and Ruoslahti 1999). In these 
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cells we studied rP2Y2 receptor internalization. Our data indicate that in unstimulated 
HEK-293 cells, actin and the P2Y2-GFP receptor are colocalized in the plasma 
membrane, most likely in a complex involving extracellular matrix binding proteins and 
integrins. Colocalization of actin and the P2Y2-GFP receptor decreased after stimulation 
of cells with UTP, indicating that actin depolymerization precedes the endocytosis of 
the receptor and facilitates its endocytosis (Fig 3.6B3). Changes in the distribution of 
the actin cytoskeleton are necessary for endocytosis, since endocytotic vesicles have 
been shown to have an actin tail that helps in their propulsion (Qualmann et. al., 2000). 
In rP2Y2-GFP receptor-expressing cells, there was complete reappearance of actin at the 
plasma membrane after 60 min of UTP stimulation (Fig 3.6E3). These observations 
strongly suggest that actin plays a role in the internalization of the P2Y2 receptor. To 
confirm the role of actin in P2Y2-GFP receptor endocytosis, we demonstrated the 
inhibitory effects of Cyto-D, an actin-disrupting agent (Sergeeva et. al., 2000), and ML-
9, a myosin light chain kinase inhibitor (Kawamura et. al., 2003). In astrocyte cultures, 
incubation of the cells with 1 µM Cyto-D for 3 h also decreased ATP-induced Ca2+ 
mobilization (Sergeeva et. al., 2000). Preincubation of the rP2Y2-GFP receptor-
transfected HEK-293 cells with a low inhibitor concentration (100 nM) for 30 min did 
not affect cell morphology. A clear inhibition of receptor endocytosis was observed 30 
min after stimulation of the cells with UTP. In the presence of Cyto-D, the activated 
receptors were not internalized, but exhibited a vesicular appearance in the plasma 
membrane, probably due to the absence of nucleotide-induced actin depolymerization 
(Fig. 3.7A2). However, after 60 min of UTP stimulation there was internalization of the 
P2Y2-GFP receptor in small vesicles (Fig. 3.7A3) despite of the presence of Cyto-D, 
suggesting that there are proteins other than actin which play a role in P2Y2 receptor 
endocytosis.  
Actin remodeling is rapid and is involved in processes like cell shape change, 
cell movement and transport of vesicles in the cytoplasm. Myosin, an enzyme that 
hydrolyzes ATP, aids in actin remodeling. Myosin light-chain kinase (MLCK) 
phosphorylates myosin and regulates its activities. ML-9 inhibited the internalization of 
the P2Y2-GFP receptor after 30 min of UTP stimulation (Fig.3.8A2), indicating that 
MLCK plays an important role in remodeling the cytoskeleton. On further stimulation 
of the cells for 60 min, an inhibition in targeting of the endocytosed receptor to the 
lysososmes was also observed (Fig. 3.8A3). These facts indicate that a normal 
remodeling of the cytoskeleton plays an important role in the formation of the 
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endocytotic complex at the plasma membrane which further influences the targeting of 
the endocytosed receptor.  
 
Endocytosis of receptors can take place via different pathways. The two most 
commonly known routes of endocytosis are via clathrin or caveolin (Sadir et. al., 2001). 
The clathrin dependent pathway involves the recruitment of arrestin and adapter 
protein-2 to form an internalization vesicle. In our study, P2Y2 receptor internalization 
was inhibited in the presence of 0.45 M sucrose, indicating that internalization of the 
receptor occurs via the clathrin-mediated pathway that is sensitive to the density of the 
medium (McArdle et. al., 2002). Furthermore, P2Y2-GFP receptor endocytosis in HEK-
293 cells was prevented by chlorpromazine, an inhibitor of the clathrin-dependent 
pathway (Fig 3.10A2) (Petris et. al, 2003). This confirms the role for clathrin in the 
receptor internalization. Another possible pathway for endocytosis in HEK-293 cells is 
caveolin mediated. Cholera toxin subunit B is known to be endocytosed exclusively by 
the caveolin- mediated pathway (Orlandi and Fishman 1998). Stimulation of P2Y2-GFP 
receptor-expressing cells with 100 µM UTP in the presence of cholera toxin subunit B 
and chlorpromazine revealed an absence of internalization of both the P2Y2-GFP 
receptor and cholera toxin, suggesting that the caveolin mediated pathway cannot be 
activated by P2Y2 receptors in HEK-293 cells (Fig 3.10C3). The lack of a contribution 
of the caveolin pathway was confirmed by the lack of effectiveness of filipin III, a 
known inhibitor of the caveolin-dependent process (Fig 3.12A3) (Orlandi and Fishman 
1998). Thus, endocytosis of the P2Y2 receptor clearly proceeds via a clathrin-mediated 
pathway. The role of plasma membrane lipids in the endocytosis of the P2Y2 receptor 
was also investigated. These lipids are normally associated with the caveolin-mediated 
endocytosis pathway (Rodal et.al., 1999). However, pretreatment of the cells with 
MβCD resulted in delayed endocytosis of the receptor and a punctate distribution of the 
endocytosed receptor (Fig 3.11A3). These facts indicate that although the endocytosis 
of the receptor proceeds via the clathrin-mediated pathway, the plasma membrane 
cholesterol content does have an influence on this pathway and that there could be lipids 
involved in the clathrin-mediated pathway. The content of plasma membrane 
cholesterol does have an influence on actin reorganization in the cell, indicating that 
treatment of the cells with MβCD not only affects the cholesterol content but also alters 
the reorganization of actin cytoskeleton. This effect is revealed by the punctate 
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distribution of the endocytosed receptor, a pattern which resembles the distribution of 
the receptor observed after treatment of the cells with Cyto-D.  
The role of the actin cytoskeleton and clathrin in modulating the endocytosis of 
GPCRs and specifically P2Y receptors has been described (Fergusson, 2001, Baurand 
et. al., 2005; Tulapurkar et. al, 2005). Clathrin-mediated endocytosis of many GPCRs is 
coupled to β-arrestin and GRKs (Reiter & Lefkowitz, 2006). Before endocytosis begins 
the invaginated membrane has to be pinched off from the plasma membrane. This 
process is mainly mediated by dynamin (Ferguson , 2001). In addition to dynamin, PLD 
has been postulated to play a role in modulating endocytosis of GPCRs (Shen et al., 
2001). Especially PLD2 has been found to regulate the endocytosis of GPCRs like the 
µ-opioid receptor (Koch et. al., 2004) and the transferrin receptor (Padrón et al., 2006). 
Moreover, PLD2 has been found to play a role not only in the agonist-dependent, but 
also in the agonist-independent endocytosis of the µ-opioid receptor (Koch et al., 2006). 
Subsequent stimulation with 100 µM UTP for 30 min prevented the internalisation of 
the receptor (Fig. 3.22B). The different trafficking of the P2Y2 receptor in cells where 
the PLD was inhibited indicates that PLD has a prominent in the early steps of 
internalisation and for further correct processing of the endocytosed receptor. However, 
future investigations have to explore the mechanism and the subtype of PLD involved. 
The possibility that beta arrestin might not be involved in the endocytosis of the P2Y 
receptors in HEK 293 cells has been postulated (Mundell and Benovic , 2000). Studies 
on platelets by Mundell (Mundell et al., 2006) revealed that the P2Y1 receptor 
endocytosis is not dependent on beta–arrestin, whereas P2Y12 endocytosis is. Our own 
studies on HEK293 cells stably expressing the P2Y2-GFP receptor did also show no 
dependence of P2Y2 endocytosis on beta-arrestin (data not shown). These observations 
indicate that, although internalization of the P2Y  and P2Y1 2 receptor is mediated by 
clathrin, there seems to be a different or additional mechanism, which might not be 
linked to beta-arrestin, as has been found for most other GPCRs endocytosed by clathrin 
(Reiter & Lefkowitz, 2006).  
 
4.3 Trafficking and compartmentalization of the rP2Y2 
receptor 
The trafficking of the P2Y2 receptor to different intracellular compartments 
determines the signals that are transmitted and the subsequent response of the cell to 
external stimuli. After chronic stimulation with agonist, the time required for receptor 
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resensitization is greater than after an acute stimulus. This effect might be due to 
differential targeting of the receptor. We observed that after 30 min of UTP stimulation 
there was targeting of the internalized P2Y2-GFP receptor to early endosomes (Fig. 
3.4A3) and upon prolonged stimulation there was colocalization of the receptor with 
lysosomes (Fig. 3.4A6). Thus, different receptor trafficking pathways are activated, 
depending on the duration of stimulation with agonist. The localization of the P2Y2 
receptor in early endosomes after a 30-min UTP stimulation indicated the possibility 
that the receptor could be recycled back to the plasma membrane. In contrast, 
stimulation of the cells for 60 min with the same concentration of UTP resulted in 
receptors targeting to lysosomes, where they would be degraded, requiring new receptor 
synthesis for resensitization. These observations could explain the differences in time 
necessary for resensitization of the cells and reappearance of the receptor at the plasma 
membrane after different lengths of receptor stimulation. The slower resensitization of 
the receptors stimulated for 60 min could also be attributable to the time required for 
transport of presynthesized receptors from the Golgi to the plasma membrane. 
Importantly, these variations in resensitization rate with duration of agonist stimulation 
are not due to the modification of P2Y2-GFP receptors, since a similar dependency for 
receptor resensitization has been observed for endogenously expressed P2Y2 receptors 
in human U937 cells (Santiago-Perez et. al., 2001).  
Receptor endocytosis is an important process by which extracellular signals 
regulate cellular functions. Regulation by receptor endocytosis has been observed for 
the epidermal growth factor receptor that signals from endosomes to promote cell 
survival (Wang et. al., 2002). Trafficking of receptors from endosomes to lysosomes 
requires the presence of associated proteins, like Rabs, whereas the farnesylation of 
RhoB is necessary for targeting to early endosomes (Prendergast 2001). Incubation of 
P2Y2-GFP receptor-expressing cells with the farnesyltransferase inhibitor FTI-277 did 
not affect UTP-induced internalization of the receptor, but due to the absence of 
farnesylation of the early endosomal coat proteins, the endocytosed receptor was not 
further trafficked to lysosomes (Fig.3.5A3). Thus, the absence of the appropriate vesicle 
coat proteins led to mistrafficking of the P2Y2-GFP receptor. FTI-277 can affect the 
reorganization of actin via the inactivation of Ras, thus affecting the initial step of 
endocytosis, namely the reorganization of the cellular cytoskeleton (Lesh et. al., 2001). 
Trafficking of receptors from the early endosomes to other compartments, such as late 
endosomes, lysosomes, or recycling endosomes, is directed via the multivesicular body 
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(Miwako et. al., 2001; Sorkin and Von Zastrow, 2002). The proteasome-mediated 
degradation of GPCRs is one of the methods for termination of receptor signaling 
(Kerkhof and Strous 2001). For the first time, we give here indication for a proteasomal 
dependent degradation pathway for P2Y2 receptor trafficking, as indicated by the 
blockage of receptor targeting to lysosomes by the proteasomal inhibitor MG-132 (Fig. 
3.13E). The complete pathway that we have investigate is summarized below in Figure 
4.1. 
 
 
Figure 4.1: Endocytotic pathway for the P2Y2 receptor. The rat P2Y2 
receptor tagged with GFP was stably expressed in HEK 293 cells. Activation of the 
P2Y2 receptor with UTP results in the remodeling of the actin cytoskeleton followed by 
endocytosis of the receptor via clathrin coated pits. The endocytosed receptor is 
trafficked from the early endosomes to the lysosomes via a proteasome dependent 
pathway.An inhibition of this pathway results in recycling of the receptor back to the 
plasma membrane. 
 
4.4 Regulation of P2Y2 receptor internalization and 
trafficking by protein kinases and phosphatase PP2A 
Our pharmacological investigation of the contribution of the protein kinases 
PKC, CaMKII, RhoA, PI3K, and MEK revealed that these kinases very likely regulate 
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the endocytosis of the P2Y2 receptor at different levels of endocytosis or resensitization. 
Phosphorylation of the P2Y2 receptor by CaMKII seems to be necessary for the correct 
processing of the receptor as pre-incubation of the cells with KN-62, results in a initial 
inhibiton of the endocytosis of the receptor. (Fig. 3.14B).This is similar to the 
observation obtained for the P2Y1 receptor (Tulapurkar et. al., 2006). Prolonged 
stimulation of the cells results in the internalization of the receptor and probable 
localization to lysosomes. Localization of the endocytosed P2Y2 receptor to lysosomes 
as well as the trafficking back to the plasma membrane is controlled by the Ca2+-
dependent PKCs isoforms α- and βI,βII. Interestingly, incubation of the cells with the 
broad spectrum PKC inhibitor GF 109203X, which inhibits PKCα,βI,βII,γ,δ and ε, does 
not interfere with the localization of the endocytosed receptor to lysosomes, but leads to 
a small delay in endocytosis. This obvious discrepancy in the effect compared to GO 
6976 (Fig.3.16C) can be explained by the fact, that GF 109203X is a weaker inhibitor of 
the Ca2+-dependent PKCs than GO6976 (Bartlett et al., 2005; Davis et al., 2000), which 
can also be seen in its lower inhibition of intracellular Ca2+ increase. The slight delay of 
the endocytosis by GF 109203X suggests that Ca2+- independent PKCs may regulate the 
correct endocytosis of the receptor (Fig. 3.17C). In contrast to the Ca2+-dependent or -
independent PKCs, the atypical PKCs ζ and δ seem to be involved in controlling the 
trafficking of the receptor to the lysosomes (Fig.3.18C) as pre-treatment of the cells 
with GO6983 hastens the localization of the endocytosed receptor with the lysosomes. 
Thus, the different PKCs seem to control distinct steps of endocytosis and reappearance 
of the P2Y  receptor. 2
The P2Y2 receptor contains amino acid residues for phosphorylation by MAPK 
and PKCs similar to other GPCRs. It has been demonstrated that the phosphorylation of 
the receptor by PKC plays an important role in the desensitization of the receptor 
(Garrad et. al;. 1998, Mundell et al., 2006). However, the role of receptor 
phosphorylation by MAPK and its effect on endocytosis has not been investigated. 
Especially most recent publications suggested a possible role of endocytosis in the 
proliferation signaling (Gobeil et al., 2006). We therefore investigated the role of 
MAPK in modulating the endocytosis of the P2Y2 receptor by pre-incubation of the 
cells with 10 µM of U0126, a MEK inhibitor (Davies et. al., 2000). We observed that 
the pre-incubation of the cells with the MEK inhibitor did not affect the localization of 
the receptor. The different endocytosis pattern of the P2Y2 receptor in pre-treated cells 
in the initial trafficking indicates an involvement of the phosphorylation by MAPKs in 
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the early phase of endocytosis (Fig.3.21B), but probably not the final destination (Fig. 
3.21 C) and the recycling of the receptor. This is evident from the aggregates of the 
receptor (Fig. 3.21D) that are present after 90 min after the withdrawal of the agonist. 
This pattern of reappearance is similar to that seen in case of untreated cells (data not 
shown). Thus, we can infer that stimulation of the P2Y2 receptor with UTP results in the 
activation of MAPK (Gao et. al., 1999, Elia et. al., 2005), which is responsible for 
further receptor signaling, but also for the proper internalization of the receptor. This is 
an interesting mechanism by which the signaling cascade initiated by the stimulated 
receptor, in addition to regulating other signaling pathways, regulates its own 
trafficking. This mechanism reveals a degree of fine tuning that is present at the level of 
cellular responses, as it is know that receptors can signal even after being endocytosed 
from the endosomes (Wang et. al., 2004). 
In addition to the kinases that are capable of directly phosphorylating the P2Y2 
receptor, kinases that are involved in remodeling of the cytoskeleton have also been 
postulated to modulate the trafficking of GPCRs (Mueller and Strange, 2004).We 
observed that the kinetics of internalization of the receptor (Fig. 3.20B) exhibited a 
pattern that is similar to that exhibited by cytochalasin-D treated cells. The absence of 
co-localization of the endocytosed receptor with lysosomes (Fig.3.20C) is similar to that 
observed in the ML-9 treated cells. These facts indicate that the kinases that modulate 
rearrangement of the too play an important role in the proper endocytosis of the receptor 
and in its trafficking. 
PI3K is a kinsae that has been implicated in modulating the endocytosis of 
GPCRs (Jo et. al., 2002) and also in the transport of vesicles (Merrifield, 2004). In case 
of the wortmannin pre-incubated cells the kinetics of endocytosis of the receptor were 
not affected but the endocytosed receptor was not trafficked to the lysosomes 
(Fig.3.19C) which then results in a prolonged delay in partial reappearance of the 
receptor. This is similar to the results obtained by Naga Prasad et. al., 2001 where they 
were able to show the involvement of the PI3K in the trafficking and sequestration of 
the β adrenergic receptor. Thus we can infer that the PI3K might modulate a variety of 
factors from its association with clathrin (Beck and Keen 1991) to vesicle transport 
which then finally influence the trafficking of the P2Y  receptor. 2
In contrast to the kinases, which control different steps in the endocytosis of the 
P2Y2 receptor as well as the trafficking back to the plasma membrane, the phosphatase 
PP2A is only involved in the regulation of the reappearance of the P2Y  receptor at the 2
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plasma membrane (Fig. 3.15C). An involvement of PP2A in the regulation of recycling 
of GPCRs has been described for the β-adrenergic receptor (Pippig et al., 1995) the 
parathyroid hormone receptor (Chauvin et al., 2002) and the P2Y1 receptor too 
(Tulapurkar et. al., 2006).  
The correct targeting of the P2Y2 receptor to lysosomes as well as its recycling 
back to the plasma membrane is very likely regulated through the activity of PI3K. 
However, whether PI3K directly phosphorylates the P2Y2 receptor and/or proteins 
involved in targeting to lysosomes or involved in the recycling of the receptor by Golgi 
vesicles is not known. This is also true for the action of CaMKII, PP2A and the PKCs. 
Furthermore, activation of RhoA kinase followed by phosphorylation of the actin 
cytoskeleton is necessary for the correct induction of P2Y2 receptor endocytosis as well 
as activation of the MAPK pathway to guaranty the correct processing of the 
endocytosed vesicles. The role of the different kinases and protein phosphatase 2A is 
summarized in Figure 4.2. 
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Figure 4.2: Role of protein kinases and protein phosphatase 2A in 
trafficking of the P2Y2 receptor. HEK 293 cells stably expressing the P2Y2-
GFP receptor were preincubated with inhibitors for different kinases and then 
stimulated with 100 µM UTP for 60 min. The cells were washed thrice with 
medium to remove agonist and further trafficking of the receptor was observed 
in the continual presence of the inhibitor 
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4.5. Different trafficking of P2Y2 receptor 
4.5.1 Trafficking by ATP and UTP 
Prolonged stimulation of cells with agonist can lead to agonist-induced 
desensitization of the receptor and termination of downstream signals. Endocytosis is 
one of the pathways by which desensitization of a receptor can occur. Receptor 
internalization is a dynamic process that involves the modification and translocation of 
a number of proteins to the plasma membrane (Claing et. al., 2002). The mechanism of 
P2Y2 receptor internalization, the trafficking of the receptor, and its 
compartmentalization after endocytosis have been investigated here.  
We found a strong correlation between the concentration of the agonist and 
endocytosis of the rP2Y2-GFP receptor (as seen in Fig. 3.3 E). Like UTP, stimulation of 
the cells with ATP exhibited a similar pattern of endocytosis of the rP2Y2-GFP 
receptor. This indicates that both UTP and ATP are equipotent at the calcium level and 
do exhibit similar degrees of receptor endocytosis at a given concentration (Fig. 3.24 B 
and C). The time course of internalization of the human P2Y2 receptor (Sromek and 
Harden, 1998) is similar to what we observe here with the rP2Y2 receptor. Although 
both ATP and UTP induce complete internalization of the P2Y2 receptor we observed a 
difference in the trafficking of the receptor when the cells were stimulated for longer 
time periods (60 min). Stimulation of cells for 30 or 60 min with 100 µM of ATP or 
UTP resulted in complete endocytosis of the receptor indicating trafficking of the 
receptor by the same endocytotic pathway. This is in agreement with our data where we 
could show that after 30 min of stimulation with 100 µM UTP there is a trafficking of 
the receptor to the early endosomes and that there was no colocalization of the receptor 
with lysosomes. However, in case of ATP-stimulated cells there seems to be a different 
pathway that is involved in the reappearance of the receptor. When the cells were 
allowed to recover for 60 min in the absence of agonist we observed a complete 
reappearance of the receptor in case of ATP-stimulated cells (Fig 3.24H) whereas only a 
partial reappearance in case of UTP-stimulated cells could be seen (Fig 3.24I). Here, 
most of the receptor remained inside the cell in vesicles, very likely lysosomes. This 
had been found in the case of UTP-mediated endocytosis of the receptor, where 60 min 
of stimulation with UTP leads to trafficking of the receptor via the proteasomal pathway 
to the lysosomes (Fig. 3.13B). In contrast, in ATP-stimulated cells, most of the 
receptors were recycled back to the plasma membrane. This is an interesting 
observation, as this seems to be one of the mechanisms by which the cells differentiate 
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in their physiological response between the stimulation of the receptor by ATP or UTP. 
This is one of the first differences that we were able to show between ATP and UTP, 
which were supposed to be equipotent agonists at the P2Y2 receptor.  
 
4.5.2. Trafficking by diadenosie polyphosphates 
 Diadenosine polyphosphates are the most ubiquitous members of the 
dinucleoside polyphosphate family. These are naturally occurring compounds that 
modulate a large number of physiological responses (Kisselev et. al., 1998). Till date it 
is not clear if there are specific receptors for the diadenosine polyphosphates (Pintor et. 
al., 2000) or act via the P2Y receptors (Laubinger et. al., 2003) we decided to 
investigate the effect of these substances in modulating the endocytosis of the P2Y2 
receptor. The different diadenosine polyphosphates did induce an increase in the 
intracellular calcium in the HEK 293 cells stably expressing the rP2Y2-GFP receptor to 
different degrees and the order of potency being ATP=UTP ≥ Ap A >Ap A≥ Ap4 3 5A 
>Ap2A (Fig. 3.26). this was the first indication that the diadenosine polyphosphates 
signal via the P2Y2 receptor and exhibit different potencies at the same receptor. When 
the cells were stimulated for 30 min with 100µM of the different diadenosine 
polyphosphates the difference in potencies of these substances on stimulating the P2Y2 
receptor became further clear. We observed that Ap2A did not induce and endocytosis 
of the receptor (Fig. 3.27A), where Ap A and Ap4 5A did induce a s significant amount of 
endocytosis of the receptor (Fig. 3.27 C and D).These results indicated that though all of 
the ApnAs were capable of causing an elevation of the intracellular calcium at 100 µM , 
they are not able to promote endocytosis of the P2Y2 receptor. We further investigated 
the time required for the endocytosed receptor to be trafficked to the lysosomes on 
stimulation of the cells with the diadenosine polyphosphates. It was interesting to 
observe that though Ap A, Ap A and Ap3 4 5A did induce complete endocytosis of the 
P2Y2 receptor, the endocytosed receptor required different duration of time to co-
localize with the lysosomes (Table 3.1). The order of potency in inducing endocytosis 
of the receptor and duration required to trafficked to the endocytosed receptor to the 
lysosome are similar to the potency exhibited by the ApnAs at the level of calcium 
signalling. Thus from the above results we can infer that the difference in the degree of 
endocytosis of the receptor and the duration required for the endocytosed receptor to be 
trafficked to the lysosomes could be specific signals used by the cell to distinguish 
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between the different ApnAs and between diadenosine polyphosphates and nucleotide 
triphosphates. 
 
4.6 P2Y2 receptor and proliferation 
The P2Y2 receptor is involved in modulation of proliferation, like the other P2Y 
receptors, namely P2Y , P2Y1 12 (Czajkowski et. al., 2004) and P2Y6 (Korcok et. al., 
2005). The role of P2Y receptors modulating proliferation has been studied in detail. 
Activation of P2Y2 receptors causes proliferation and/or migration of human epidermal 
keratinocytes, lung epithelial tumor cells, glioma cells, and smooth muscle cells 
(Wilden et al., 1998; Tu et al., 2000; Seye et al., 2002; Schäfer et al., 2003, Greig et al., 
2003). Cell proliferation in response to P2Y2 receptor activation is associated with the 
activation of PI3-K, ERK1/2 and the expression of the early response protein c-fos 
(Muscella et al., 2003, Neary et al., 2003), PKC (Muscella, et. al., 2004), CDKs (Lee 
and Han 2006) and NF-κB (Korcok et. al., 2005, Schäfer et al., 2006) which are 
regulated from the signals emanating from the stimulation of the receptor. In case of the 
P2Y2 receptor, it has been shown to modulate the cell cycle (Miyagi et. al., 1996; 
Schäfer et al., 2006; 2003). The subtypes of P2 receptors involved in the anticancer 
activity of adenine nucleotides are largely unresolved, but P2Y  and P2Y1 2 receptors are 
considered as targets for tumor cell antiproliferation. Consistent with a role for P2Y2 
receptors in cell proliferation, P2Y2 receptor mRNA expression is down-regulated 
during cell differentiation (Martin et al., 1997). The P2Y2 receptor is up-regulated in 
thymocytes as an immediate early gene response (Koshiba et al., 1997) and in injured 
and stressed tissues (Turner et al., 1997; Seye et al., 2002). Thus, it is very important to 
evaluate whether ATP and UTP induced activation of the P2Y2 receptor leads to similar 
or different degrees of proliferation. In terms of endocytotic kinetics both 100 µM ATP 
or UTP resulted in complete internalization of the receptor. We therefore expected an 
equal degree of proliferation induced upon stimulation of the cells with either ATP or 
UTP. However, even in the presence of the P2Y1 receptor antagonist MRS2179, a 
small, but significant difference in the proliferation potency of ATP as compared to 
UTP was observed, already starting at concentrations of 20 µM (data not shown). These 
data are in complete correlation with our previous data (Schafer et. al., 2003), where in 
the A549 cells we observed this difference too. In case of A549 cells this difference 
between ATP and UTP in modulating the proliferation is markedly observed as the 
A549 cells lack the P2Y  receptor. 1
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When the cells were stimulated with diadenosine polyphosphates it was 
observed that the dadenosine polyphosphates stimulated proliferation to a larger extent 
that that induced by either ATP or UTP (Table 3.2). The reason for this increased level 
of proliferation could be either due to the activation of different signal transduction 
pathways or due to hydrolysis products of the diadenosine polyphopsphates which could 
act as an additional trigger for proliferation and thus result is increased proliferation that 
that obtained with ATP/UTP. We observed that even a pre-incubated of the cells with 
α,β-Me-ADP, an inhibitor of the extracellular ectonucleotidases (Vollmayer et. 
al.,2003), before stimulation with diadenosine polyphosphates did not significantly alter 
the proliferative response (Table 3.2). Thus form the above results we can infer that the 
diadenosine polyphosphates stimulate a different pathway or and additional pathway 
that is not activated by either ATP or UTP that results in the significantly increased 
proliferation induced by these substances. 
Thus far, the strength of a signal elicited by an agonist could be correlated by its 
ability to induce a stronger degree of internalization. However, in the case of the P2Y2 
receptor, there is complete endocytosis of the receptor induced by both ATP and UTP 
and therefore, some thus far unknown signaling protein seems to be differently 
activated. Based on these results that one may speculate that the strength of the 
endocytosis is correlated with the strength of the physiological reposne of the cell which 
in this case is proliferation. One possible candidate could be ERK1/2, as it has been 
shown to be activated four-fold higher upon activation of the CCR7 chemokine receptor 
by CCL19 than by CCL21 (Kohout et al., 2004). 
 Whether ATP or UTP induce different internalization mechanisms of the P2Y2 
receptor, as has been found for the CC chemokine receptor (Kohout et al., 2004) and for 
the µ-opioid receptor (Johnson et al., 2006), is not known. The latter result is especially 
important, as it has been found that the µ-opioid agonist DAMGO ([D-Ala2,N-Me-
Phe4,Gly5-ol]-enkephalin) induces arrestin-2 translocation to the plasma membrane, 
whereas morphin does not. This difference of the two agonists is consistent with their 
ability to induce internalization of the µ-opioid receptor (Johnson et al., 2006). 
Moreover, β-arrestins scaffold members of the MAPK signaling cascade (Reiter & 
Lefkowitz, 2006). Thus, the role of β-arrestins in the internalization and the modulation 
of proliferative signals of the P2Y2 receptor needs further in-depth examination. A 
comparison of the different endocytotic/trafficking and signaling to the nucleus by 
ATP/UTP/Ap A are summarized in Fig. 4.3. n
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Figure 4.3: Activation of P2Y2 receptor endocytosis/trafficking and signalling to 
the nucleus by ATP / UTP / Ap As via the P2Y  receptor. n 2
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4.7 Conclusion 
Taken together, our results support a model for endocytosis of the P2Y2 receptor 
that involves active participation of the cytoskeleton via a clathrin-dependent pathway, 
and trafficking of the receptor from endosomes to lysosomes that most likely involves 
receptor ubiquitination. We also found evidence that in addition to the role of 
cytoskeleton and clathrin in the modulation of endocytosis of the P2Y2 receptor, PLD 
regulates the endocytosis of the P2Y2 receptor. Inhibition of PLD delays the endocytosis 
of the receptor, whereas the inhibition of the MAPK modulated the distribution of the 
internalized receptor. In addition to this we were also able to add a new aspect to the 
activation of MAPK by the P2Y2 receptor. MAPKs do not only play an important role 
in modulating the proliferative activity by the P2Y2 receptor (Shen et.al., 2004, 
Muscella et. al., 2003) but also affect the trafficking of the receptor. From the receptor 
trafficking and proliferation experiments presented here, we could demonstrate for the 
first time that at the P2Y  receptor ATP and UTP are equipotent agonists at the P2Y2 2 
receptor only at the level of calcium response whereas in the further downstream events, 
like trafficking of the receptor and modulation of proliferation by the P2Y2 receptor 
they exhibit different regulatory mechanisms indicating that they stimulate different 
pathways in trafficking of the internalized receptor. In addition to the nucleotides ATP 
and UTP diadenosine polyphosphates also modulate the trafficking of the P2Y2 
receptor. The clear association of defined molecular steps in P2Y2 receptor trafficking 
found here will enable us to design strategies to allow long-term stimulation and 
signaling of this receptor subtype. Thus, the P2Y2 receptor is an intriguing new target 
for anti-inflammatory, immunomodulatory and antiproliferative therapies in 
neurodegenerative diseases, cancer and atherosclerosis (Abbracchio et al. 2006; 
Lazarowski et. al., 1997; Luttikhuizen et al., 2004) for which an understanding of the 
consequences of continuous stimulation of this nucleotide receptor is important.  
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5. ZUSAMMENFASSUNG 
Extrazelluläre Nukleotide üben eine große Anzahl von physiologischen Effekten 
durch die Aktivierung von P2Y Rezeptoren aus. Die Aktivität der metabotropen P2Y 
Rezeptoren, die zu der Familie der G-Protein-gekoppelten Rezeptoren gehören, wird 
durch Endozytose reguliert. Von den acht Subtypen der P2Y Rezeptoren 
(P2Y1,2,4,6,11,12,12,14) ist der P2Y2 Rezeptor einzigartig, da er equipotent auf Adenin- und 
Uridin-Nukleotide anspricht. Zusätzlich zu Purin- und Pyrimidin-
Nukleosidtriphosphaten können P2Y Rezeptoren auch durch Diadenosinpolyphosphate 
aktiviert werden. 
 Da die Proteine, die den intrazellulären Transport des endozytierten P2Y2 
Rezeptors regulieren, nicht bekannt sind, haben wir den P2Y2 Rezeptor der Ratte mit 
grün-fluoreszierendem Protein (GFP) markiert und funktional in HEK-293 Zellen 
exprimiert, um die Translokation des Rezeptors in lebenden Zellen mittels konfokaler 
Mikroskopie zu beobachten. Die funktionelle Expression des Rezeptors wurde durch 
Messung des Anstiegs der intrazellulären Ca2+ Konzentration ([Ca2+]) nach Applikation 
ansteigender Konzentrationen von ATP oder UTP bestätigt. Die Stimulation mit den 
Agonisten bewirkte eine zeitabhängige Translokation des P2Y2 Rezeptors von der 
Plasmamembran in das Cytoplasma. Das Ausmaß der Endozytose des Rezeptors war 
von der Konzentration des Agonisten abhängig. Nach der Stimulation der Zellen mit 
UTP wurde zuerst eine Kolokalisation des endozytierten Rezeptors mit frühen 
Endosomen und dann mit Lysosomen beobachtet. Die Inhibierung der Rezeptor-
Endozytose durch hoch-viskoses Medium oder Chlorpromazin in Gegenwart von UTP 
weist auf die Internalisierung des Rezeptors durch den Clathrin-vermittelten Signalweg 
hin. Die Nichtbeteiligung des Caveolin-vermittelten Signalweges wurde bestätigt, da 
Filipin-III nicht die Kinetik der Endozytose des P2Y2-GFP Rezeptors beeinflußte. Die 
Steuerung des Rezeptors von den Endosomen zu den Lysosomen scheint den 
Proteasom-Signalweg einzuschließen, da die Inhibierung des Proteasomen-Komplexes 
das Recycling des Rezeptors zur Plasmamembran erhöhte. Ein interessanter Befund der 
Studie ist die Tatsache, dass ATP und UTP unterschiedliche Transport-Signalwege für 
den endozytierten Rezeptor auslösen, obwohl sie eine identische Potenz hinsichtlich der 
Ca2+-Freisetzung besitzen. Dies ist aus den unterschiedlichen Kinetiken des 
Wiedererscheinens des endozytierten P2Y2-GFP Rezeptors an der Zelloberfläche 
ersichtlich, je nach Stimulation durch ATP bzw. UTP. Am intrazellulären Transport des 
endozytierten P2Y 2+ Rezeptors sind die Ca -Calmodulin abhängige Proteinkinase II 2
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(CaMKII), PP2A, Proteinkinase C, RhoA-Kinase, PI3-Kinase und Phospholipase D2 
(PLD ) beteiligt. Dies konnte mittels Vorbehandlung von P2Y2 2-GFP Rezeptor-
exprimierenden Zellen mit spezifischen Inhibitoren dieser Proteine nachgewiesen 
werden, da diese den Zeitverlauf sowohl von der Endozytose als auch des 
Wiedererscheinens des Rezeptors an der Zelloberfläche veränderten. Die 
Diadenosinpolyphosphate haben unterschiedliche Potenz in der Erhöhung von [Ca2+]i, 
der Induzierung der Endozytose des P2Y2 Rezeptors, seines intrazellulären Transportes 
und der P2Y2 Rezeptor-vermittelten Proliferation. In der Reihenfolge 
Ap A>Ap A≥Ap A>>Ap A nahm die Wirksamkeit am P2Y4 3 5 2 2 Rezeptor für die 
angeführten Prozesse ab. 
Zusammenfassend kann gesagt werden, dass in dieser Studie zum ersten Mal 
gezeigt wurde, dass (i) eine starke Korrelation zwischen der Konzentration des 
Agonisten und der dadurch bedingten Endozytose des P2Y2 Rezeptors besteht, (ii) ATP 
und UTP einen unterschiedlichen intrazellulären Transport des endozytierten Rezeptors 
auslösen, (iii) der Proteasom-Signalweg sehr wahrscheinlich an dem intrazellulären 
Transport des P2Y2 Rezeptors beteiligt ist, (iv) dieser intrazelluläre Transport durch 
eine Reihe von Proteinkinasen und zytosolischen Proteinen kontrolliert wird, die 
dadurch letztendlich die weiteren Reaktionen der Zelle bestimmen und (v) 
Diadenosinpolyphosphate den intrazellulären Transport des P2Y2 Rezeptors und auch 
die durch den Rezeptor stimulierte Proliferation modulieren.  
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Abstract 
Extracellular nucleotides exert a large number of physiological effects through 
activation of P2Y receptors. The activity of the metabotropic P2Y receptors, which 
belong to the family of G protein-coupled receptors (GPCRs), is regulated by 
endocytosis. Out of the eight P2Y subtypes that have been characterized,(1,2,4,6,11,12,13,14),  
the P2Y2 is unique in that it responds equipotently to adenine and uridine triphosphates 
in terms of Ca2+-release. In addition to purine or pyrimidine nucleoside triphosphates, 
P2Y receptors can also be activated by diadenosine polyphosphates. 
 As the proteins which regulate trafficking of the endocytosed P2Y2 receptor are 
not known, we investigated this by functional expression of the rat P2Y2 receptor, 
tagged with green fluorescent protein (GFP) in HEK-293 cells and visualised receptor 
translocation in live cells by confocal microscopy. Agonist stimulation revealed a time- 
and concentration-dependent translocation of the receptor from the plasma membrane to 
the cytoplasm. Colocalization of the endocytosed P2Y2 receptor with clathrin, early 
endosomes and lysosomes in the stated sequence upon stimulation of the cells with UTP 
reveals internalization through the clathrin-, but not the caveolin-mediated pathway: 
The proteasome pathway very likely is involved in targeting of the receptor from 
endosomes to lysosomes, because proteasomal inhibition increased receptor recycling 
back to the plasma membrane. An interesting finding of the study was that ATP and 
UTP initiated different trafficking pathways for the endocytosed receptor were 
equipotent at the P2Y receptor in terms of the Ca2+2  response. Pharmacological 
investigation of the trafficking revealed that CaMKII, PP2A, PKCs, RhoA kinase, PI3K 
and PLD  are involved in modulating the trafficking of the endocytosed P2Y2 2 receptor. 
Different potencies in elevating [Ca2+]i, inducing endocytosis or modulating trafficking 
of the P2Y  receptor and proliferation with a potency order of Ap A>Ap A≥Ap2 4 3 5A 
>>Ap A could be demonstrated. 2
In conclusion through this study we were able to demonstrate for the first time 
that (i) there is a strong correlation between the concentration of the agonist and 
endocytosis of the P2Y2-GFP receptor; (ii) ATP and UTP induce different trafficking of 
the endocytosed receptor; (iii) the proteasomal pathway is involved in trafficking of the 
P2Y  receptor ; (iv) trafficking of the P2Y2 2 receptor is controlled by a orchestra of 
kinases and cytosolic proteins which finally regulate the fate of the cell and (v) 
diadenosine polyphosphates also modulate the trafficking of the P2Y2 receptor and also 
P2Y  receptor modulated proliferation.  2
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7 LIST OF ABBREVEATIONS
 
AC     Adenylyl cyclase 
ADP     Adenosine 5’-diphosphate 
ATP     Adenosine 5’-triphosphate 
Ap A    Diadenosine polyphosphate n
Ap A    Diadenosine diphosphate 2
Ap A    Diadenosine triphosphate 3
Ap A    Diadenosine tetraphosphate 4
Ap A    Diadenosine pentphosphate 5
BSA    Bovine serum albumin 
BrdU     5-Bromo-2’-deoxyuridine 
[Ca2+]     Intracellular calcium concentration i
2+CaMKII    Ca /calmodulin-dependent protein kinase II 
cAMP     Cyclic adenosinemonophosphate 
CNS     Central nerve system 
CTxB    cholera toxin subunit B conjugated to Alexa Fluor 555  
Cyto-D   Cytochalasin-D 
DAG    Diacylglycerol 
DMEM    Dulbecco’s Modified Eagle’s Medium 
DNA     Deoxyribonucleic acid 
DOTAP N-[1-(2,3-dioleoyloxy)propyl]-N,N,N- 
trimethylammoniummethyl sulfate  
EDTA    Ethylene diamaine tetra acetic acid 
EEA-1    Early endosome antigen-1  
EGF     Epidermal growth factor 
EGFR     Epidermal growth factor receptor 
ERK     Extracellular regulated kinase 
FCS     Fetal calf serum 
FTI-277   Farnesyl transferase inhibitor 
Fura-2/AM    Fura-2/Acetoxymethyl Ester 
GF-109203X    Bisindolylmaleimide 
G418     Geneticin sulfate 
GFP    Green fluorescent protein 
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GRK    GPCR coupled kinase 
HEK-293    Human embryonic kidney cells 
LAMP-1   Lysosome-associated marker protein-1 
MAPK   Mitogen-activated protein kinase 
MβCD    Methyl-beta-cyclodextrin 
MEK     Mitogen-activated protein kinase kinase 
MG-132   Inhibitor of Proteasomal complex 
ML-9     Inhibitor of myosin light chain kinase 
MLCK   Myosin light chain kinase 
PBS     Phosphate-buffered saline 
PCR    Polymerase Chain Reaction 
PI 3-Kinase    Phosphatidylinositol 3-kinase 
PKC    Protein kinase C 
PLA2     Phospholipase A2 
PLC     Phospholipase C 
PLD     Phospholipase D2 2
PLL     Poly-L-lysine 
Pyk2     proline-rich tyrosine kinase 2 
Raf     A mitogen-activated protein kinase kinase kinase 
Ras     A small GTPase; one of the oncogenes family 
Rho A    A small GTPase 
SERCA    sarcoplasmic/endoplasmic reticulum calcium ATPase 
Src     A nonreceptor tyrosine kinase 
UDP    Uridine diphosphate 
UTP    Uridine triphosphate 
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